Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
AGREEMENT AND PLAN OF ORGANIZATION
Dated as of the 23rd day of October, 1997
by and between
HEALTHWORLD CORPORATION
and
▇▇▇▇▇▇▇ ▇▇▇▇▇▇
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
TABLE OF CONTENTS
Page No.
1 The Organization................................................................................................. -7-
----------------
1.1 Organization............................................................................. -7-
------------
1.2 Directors and Officers................................................................... -8-
----------------------
2 Conversion of Stock.............................................................................................. -8-
-------------------
2.1 Manner of Conversion..................................................................... -8-
--------------------
2.2 Beneficial Ownership of Shares........................................................... -8-
------------------------------
2.3 Allocation of Shares..................................................................... -8-
--------------------
3 Delivery of U.K. Company Stock and Healthworld Stock; Disclaimer of Rights....................................... -10-
--------------------------------------------------------------------------
4 Closing......................................................................................................... -10-
-------
5 Representations And Warranties of the U.K. Stockholder.......................................................... -11-
------------------------------------------------------
5.1 Due Organization........................................................................ -11-
----------------
5.2 Prohibited Activities................................................................... -12-
---------------------
5.3 Capital Stock of the Company............................................................ -12-
----------------------------
5.4 Transactions in Capital Stock........................................................... -13-
-----------------------------
5.5 No Bonus Shares......................................................................... -13-
---------------
5.6 Subsidiaries............................................................................ -13-
------------
5.7 Predecessor Status; etc................................................................. -13-
-----------------------
5.8 Spin-off by the Company................................................................. -14-
-----------------------
5.9 Financial Statements.................................................................... -14-
--------------------
5.10 Liabilities and Obligations............................................................. -14-
---------------------------
5.11 Accounts and Notes Receivable........................................................... -15-
-----------------------------
5.12 Permits and Intangibles................................................................. -15-
-----------------------
5.13 Environmental Matters................................................................... -16-
---------------------
5.14 Personal Property....................................................................... -16-
-----------------
5.15 Significant Customers; Material Contracts and Commitments............................... -16-
---------------------------------------------------------
5.16 Real Property........................................................................... -17-
-------------
5.17 Insurance............................................................................... -17-
---------
5.18 Compensation; Employment Agreements; Organized Labor Matters. .......................... -18-
------------------------------------------------------------
5.19 Employee Benefits....................................................................... -21-
-----------------
5.20 Conformity with Law; Litigation......................................................... -22-
-------------------------------
5.21 Taxes................................................................................... -22-
-----
5.22 No Violations........................................................................... -24-
-------------
5.23 Government Contracts.................................................................... -25-
--------------------
-i-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
Page No. 8
5.24 Absence of Changes...................................................................... -25-
------------------
5.25 Deposit Accounts; Powers of Attorney.................................................... -26-
------------------------------------
5.26 Brokers and Agents...................................................................... -27-
------------------
5.27 Relations with Governments.............................................................. -27-
--------------------------
5.28 Disclosure.............................................................................. -27-
----------
5.29 Authority; Ownership. ................................................................. -28-
--------------------
5.30 Preemptive Rights....................................................................... -28-
-----------------
5.31 No Intention to Dispose of Healthworld Stock............................................ -28-
--------------------------------------------
6 Representations of Healthworld.................................................................................. -28-
------------------------------
6.1 Due Organization........................................................................ -28-
----------------
6.2 Authorization........................................................................... -29-
-------------
6.3 Capital Stock of Healthworld............................................................ -29-
----------------------------
6.4 Transactions in Capital Stock........................................................... -29-
-----------------------------
6.5 Liabilities and Obligations............................................................. -29-
---------------------------
6.6 Conformity with Law; Litigation......................................................... -29-
-------------------------------
6.7 Validity of Obligations................................................................. -30-
-----------------------
6.8 Limited Business Conducted.............................................................. -30-
--------------------------
7 Covenants Prior to Closing...................................................................................... -30-
--------------------------
7.1 Access and Cooperation; Due Diligence................................................... -30-
-------------------------------------
7.2 Conduct of Business Pending Closing..................................................... -30-
-----------------------------------
7.3 Prohibited Activities................................................................... -31-
---------------------
7.4 No Shop................................................................................. -33-
-------
7.5 Further Assurances...................................................................... -33-
------------------
7.6 Agreements.............................................................................. -33-
----------
7.7 Notification of Certain Matters......................................................... -33-
-------------------------------
7.8 Amendment of Schedules.................................................................. -34-
----------------------
7.9 Cooperation in Preparation of Registration Statement.................................... -34-
----------------------------------------------------
8 Conditions Precedent to Obligations of the U.K. Stockholder..................................................... -35-
-----------------------------------------------------------
8.1 Representations and Warranties; Performance of Obligations by Healthworld............... -35-
-------------------------------------------------------------------------
8.2 Satisfaction............................................................................ -35-
------------
8.3 No Litigation........................................................................... -35-
-------------
8.4 Opinions of Counsel..................................................................... -35-
-------------------
8.5 Consents and Approvals.................................................................. -35-
----------------------
8.6 No Material Adverse Change.............................................................. -36-
--------------------------
8.7 Secretary's Certificates; Good Standing................................................. -36-
---------------------------------------
8.8 Simultaneous Closings................................................................... -36-
--------------------
-ii-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
Page No.
9 Conditions Precedent to Obligations of Healthworld.............................................................. -36-
--------------------------------------------------
9.1 Representations and Warranties; Performance of Obligations.............................. -36-
----------------------------------------------------------
9.2 Satisfaction............................................................................ -36-
------------
9.3 No Litigation........................................................................... -37-
-------------
9.4 Opinion of Counsel...................................................................... -37-
------------------
9.5 Consents and Approvals.................................................................. -37-
----------------------
9.6 No Material Adverse Change.............................................................. -37-
--------------------------
9.7 Secretary's Certificates................................................................ -37-
------------------------
9.8 Stockholder's Release................................................................... -37-
---------------------
9.9 Termination of Related Party Agreements................................................. -37-
---------------------------------------
9.10 Simultaneous Closings................................................................... -38-
---------------------
9.11 Cater Share Purchase.................................................................... -38-
--------------------
10 Covenants of Healthworld and the U.K. Stockholder after Closing................................................. -38-
---------------------------------------------------------------
10.1 Release From Guarantees; Repayment of Certain Obligations............................... -38-
---------------------------------------------------------
10.2 Preservation of Tax and Accounting Treatment............................................ -38-
--------------------------------------------
10.3 Preparation and Filing of Tax Returns................................................... -38-
-------------------------------------
10.4 Conformity With ▇▇▇▇▇▇▇▇/▇▇▇▇▇▇ Letter of Intent Regarding Governance................... -39-
----------------------------------------------------------
Governance...................................................................................................... -39-
11 Indemnification................................................................................................. -39-
---------------
11.1 General Indemnification by the U.K. Stockholder......................................... -39-
-----------------------------------------------
11.2 Indemnification by Healthworld.......................................................... -40-
------------------------------
11.3 Third Person Claims..................................................................... -40-
-------------------
11.4 Exclusive Remedy........................................................................ -42-
----------------
11.5 Limitations on Indemnification.......................................................... -42-
------------------------------
12 Termination of Agreement........................................................................................ -43-
------------------------
12.1 Termination............................................................................. -43-
-----------
12.2 Liabilities in Event of Termination..................................................... -43-
-----------------------------------
13 Non-Competition; Non-Disclosure................................................................................. -43-
-------------------------------
13.1 Non-Competition......................................................................... -43-
---------------
13.2 Nondisclosure........................................................................... -45-
-------------
13.3 Injunctive Relief; Damages.............................................................. -46-
--------------------------
13.4 Reasonable Restraint.................................................................... -46-
--------------------
13.5 Severability; Reformation............................................................... -46-
-------------------------
-iii-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
Page No.
13.6 Independent Covenant.................................................................... -47-
--------------------
13.7 Survival................................................................................ -47-
--------
14 Federal Securities Act Representations.... ..................................................................... -47-
--------------------------------------
14.1 Compliance with Law..................................................................... -47-
-------------------
14.2 Economic Risk; Sophistication........................................................... -47-
-----------------------------
15 Registration Rights............................................................................................. -48-
-------------------
15.1 Piggyback Registration Rights........................................................... -48-
-----------------------------
15.2 Registration Procedures................................................................. -48-
-----------------------
15.3 Underwriting Agreement.................................................................. -49-
----------------------
15.4 Availability of Rule 144................................................................ -49-
------------------------
16 General......................................................................................................... -49-
-------
16.1 Cooperation............................................................................. -49-
-----------
16.2 Successors and Assigns.................................................................. -49-
----------------------
16.3 Entire Agreement........................................................................ -49-
----------------
16.4 Counterparts............................................................................ -50-
------------
16.5 Expenses................................................................................ -50-
--------
16.6 Notices................................................................................. -51-
-------
16.7 Governing Law........................................................................... -52-
-------------
16.8 Exercise of Rights and Remedies......................................................... -52-
-------------------------------
16.9 Time.................................................................................... -52-
----
16.10 Reformation and Severability............................................................ -52-
----------------------------
16.11 Remedies Cumulative..................................................................... -52-
-------------------
16.12 Captions................................................................................ -52-
--------
16.13 Amendments and Waivers.................................................................. -52-
----------------------
-iv-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
AGREEMENT AND PLAN OF ORGANIZATION
THIS AGREEMENT AND PLAN OF ORGANIZATION (the "Agreement") is made as of the
_______ day of October, 1997, by and between:
Healthworld Corporation, a Delaware corporation ("Healthworld"), and
▇▇▇▇▇▇▇ ▇▇▇▇▇▇ (the "U.K. Stockholder"), residing at ▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇,
▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇▇▇.
WHEREAS, the U.K. Stockholder is the registered and beneficial owner with
full title guarantee of a portion of the issued share capital of ▇▇▇▇▇▇
Marketing Limited, a company incorporated in England and Wales with registered
no. 1385429 (the "Company"); and
WHEREAS, the remainder of the issued share capital of the Company is owned
by ▇▇▇▇▇▇ Marketing Group Limited (the "U.K. Company"), which is wholly-owned by
▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ("▇▇▇▇▇▇"); and
WHEREAS, Healthworld was formed on September 12, 1996, in the State of
Delaware, for the purpose of effecting the Healthworld Plan of Organization; and
WHEREAS, ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ("Garnham") owns a portion of the issued share
capital of Effective Sales Personnel Ltd. (f/k/a ▇▇▇▇▇▇ Headcount Limited), a
company incorporated in England and Wales with registered no. 2998311 ("ESP");
and
WHEREAS, ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ("Moreton") owns a portion of the issued share
capital of PDM Communications Limited, a company incorporated in England and
Wales with registered no. 1324588 ("PDM"); and
WHEREAS, the U.S. Stockholders collectively own all of the issued and
outstanding shares of Girgenti, Hughes, ▇▇▇▇▇▇ & ▇▇▇▇▇▇▇▇, Inc. ("GHBM"), a New
York corporation, Black Cat Graphics, Inc. ("Black Cat"), a New York
corporation, Medical Education Technologies, Inc. ("MET"), a New York
corporation, Brand Research Corporation ("Brand Research"), a New York
corporation, GHBM, Inc. ("GHBMINC"), a New York corporation and Syberactive,
Inc. ("Syberactive"), an Illinois corporation (each of GHBM, Black Cat, MET,
Brand Research, GHBMINC and Syberactive are hereafter referred to individually
as a "U.S. Company" and collectively as the "U.S. Companies"); and
WHEREAS, the U.S. Stockholders desire to contribute all of their shares of
stock in the U.S. Companies into Healthworld in exchange for Healthworld Stock,
the U.K. Stockholder
-1-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
desires to contribute all of his shares of stock in the Company into Healthworld
in exchange for Healthworld Stock, ▇▇▇▇▇▇ desires to contribute all of his
shares of stock in the U.K. Company into Healthworld in exchange for Healthworld
Stock, Moreton desires to contribute all of his shares of stock in PDM into
Healthworld in exchange for Healthworld Stock, and Garnham desires to contribute
all of his shares of stock in ESP into Healthworld in exchange for Healthworld
Stock, all of the foregoing to occur contemporaneously with the Pricing of the
IPO; and
WHEREAS, all of the foregoing contributions together with the IPO
constitute the "Healthworld Plan of Organization"; and
WHEREAS, the parties intend that the Healthworld Plan of Organization shall
qualify as tax-free under Section 351 of the United States Internal Revenue Code
of 1986, as amended (the "Code") and , where applicable, as a reorganization
within the meaning of Section 368 of the Code; and
WHEREAS, Cater owns a portion of the issued share capital of ▇▇▇▇▇▇ ▇▇▇▇▇
Limited, a company incorporated in England and Wales with registered no. 3196839
("MCL"); and
WHEREAS, Cater desires to transfer her shares of MCL in consideration for a
variation to her service agreement and not in exchange for Healthworld Stock;
and
WHEREAS, unless the context otherwise requires, capitalized terms used in
this Agreement or in any Schedule attached hereto and not otherwise defined
shall have the following meanings for all purposes of this Agreement:
"1933 Act" means the United States Securities Act of 1933, as amended.
"1934 Act" means the United States Securities Exchange Act of 1934, as
amended.
"Absolute Representations" shall have the meaning set forth in subparagraph
(ii) of the preliminary paragraphs of Section 5.
"Acquired Party" means any of the U.K. Company and any Subsidiary thereof.
"Affiliates" has the meaning set forth in Section 5.8.
"Aggregate Number of Founder Shares" has the meaning set forth in Section
2.3.
"Balance Sheet Date" shall mean November 30, 1996.
-2-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
"▇▇▇▇▇▇" means ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, residing at ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇▇▇
▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇-▇▇▇▇.
"Cater" means ▇▇▇▇▇▇ ▇▇▇▇▇, residing at Back of Beyond, 76 The High Street,
Ardingly, ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇▇▇.
"Closing" has the meaning set forth in Section 4.
"Closing Date" has the meaning set forth in Section 4.
"Code" has the meaning set forth in the introductory paragraphs of this
Agreement.
"Company" has the meaning set forth in the introductory paragraphs of this
Agreement.
"Company Financial Statements" has the meaning set forth in Section 5.9.
"Company Stock" has the meaning set forth in Section 2.1.
"Contributing Minority Stockholders" means the U.K. Stockholder, Garnham
and Moreton.
"Disclosed Schemes" has the meaning set forth in Section 5.19.
"Disclosure Schedule" has the meaning set forth in the preliminary
paragraph of Section 5.
"▇▇▇▇▇▇▇▇▇" means ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, residing at ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇
▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇-▇▇▇▇.
"Encumbrance" means a mortgage, charge (whether fixed or floating), pledge,
lien, option, restriction, right of first refusal, right of preemption, third
party right or interest, other encumbrance or security interest of any kind and
whether legal or equitable, or another type of preferential arrangement
(including, without limitation, a title transfer and retention arrangement)
having similar effect.
"Expiration Date" has the meaning set forth in Section 5.
"Garnham" means ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, residing at ▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇,
▇▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇▇▇.
-3-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
"▇▇▇▇▇▇▇▇" means ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, residing at ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇,
▇▇▇ ▇▇▇▇ ▇▇▇▇▇.
"▇▇▇▇▇▇▇▇/▇▇▇▇▇▇ Letter of Intent" means a certain letter of intent of
November 14, 1996, as amended, regarding a reorganization of the U.S. Companies
and the U.K. Company in connection with a contemplated IPO, executed by
▇▇▇▇▇▇▇▇, the U.S. Companies, the U.K. Stockholder, the U.K. Company and the
Subsidiaries of the U.K. Company.
"Healthworld" has the meaning set forth in the introductory paragraphs of
this Agreement.
"Healthworld License Agreement" means that certain License Agreement dated
February 27, 1997 by and between Healthworld and Healthworld B.V. pursuant to
which Healthworld has licensed from Healthworld B.V., among other things, the
right to use the name "Healthworld."
"Healthworld Plan of Organization" has the meaning set forth in the
introductory paragraphs of this Agreement.
"Healthworld Stock" means the common stock, par value $0.01 per share, of
Healthworld.
"▇▇▇▇▇▇" means ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, residing at ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇ ▇▇,
▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇.
"IPO" means the initial public offering of Healthworld Stock pursuant to
the Registration Statement.
"Key Consultant Agreement" means any agreement with a consultant providing
for the services of an individual and requiring payment to the consultant of not
less than (pound)93,750 per annum.
"Key Employee" means any employee whose compensation is not less than
(pound)93,750 per annum.
"Material Adverse Effect" has the meaning set forth in Section 5.1.
"▇▇▇▇▇▇" means ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, residing at ▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇,
▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇▇▇.
"Moreton" means ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, residing at "Southcroft," ▇▇▇▇▇▇ ▇▇▇▇,
▇▇▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇▇▇.
-4-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
"Offering Price" means (i) the offering price in the IPO if the Closing
Date occurs contemporaneously with the Pricing and (ii) the proposed mid-range
offering price in the IPO as reflected in the Registration Statement, as most
recently amended, if the Closing Date occurs prior to the Pricing.
"Organization" means the contribution of all the shares of stock of the
U.K. Company and all of its Subsidiaries (with the exception of Healthworld
B.V.) to the capital of Healthworld in exchange for shares of Healthworld Stock.
"Prevailing Conversion Rate" means the prevailing exchange rate, as shown
in The Financial Times, between the U.S. dollar and the U.K. pound sterling at
the close of business on the business day immediately prior to the Closing Date.
"Pricing" means the time and date of determination by Healthworld and the
Underwriters of the public offering price of the shares of Healthworld Stock in
the IPO and the execution of the Underwriting Agreement by Healthworld and the
Underwriters.
"Registration Statement" means that certain registration statement on Form
S-1 (Registration No. 333-34751) and any amendments thereto covering the shares
of Healthworld Stock to be issued in the IPO.
"Returns" means any returns, reports or statements (including any
information returns) required to be filed for purposes of a particular Tax or
Taxation.
"Schedule" means each Schedule attached hereto, which shall reference the
relevant sections of this Agreement, on which parties hereto disclose
information as part of their respective representations, warranties and
covenants.
"SEC" means the United States Securities and Exchange Commission.
"Sister Company Agreements of Organization" has the meaning set forth in
Section 1.1.2.
"▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Employment Agreement" means that certain Employment
Agreement by and between Healthworld and ▇▇▇▇▇▇ ▇▇▇▇▇▇▇, dated August 18, 1997,
pursuant to which Healthworld has engaged the services of ▇▇▇▇▇▇ ▇▇▇▇▇▇▇.
"Subsidiary" has the meaning given thereto in Section 736 and 736A of the
United Kingdom Companies ▇▇▇ ▇▇▇▇ as substituted by ▇▇▇▇▇▇▇ ▇▇▇ ▇▇ ▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇▇▇ Companies Act of 1989.
-5-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
"Taxation" or "Tax" means all forms of tax, duty, levy or other imposition
whenever and by whatever authority imposed and whether of the United Kingdom or
elsewhere, including (without limitation) income tax, corporation tax, advance
corporation tax, capital gains tax, inheritance tax, value added tax, customs
duties, rates, stamp duty, stamp duty reserve tax, national insurance and social
security or other contributions, and any interest, penalty, fine or surcharge in
connection with any such taxation.
"Taxes Act" means the United Kingdom Income and Corporation Taxes ▇▇▇ ▇▇▇▇.
"Underwriters" means Unterberg Harris and Pennsylvania Merchant Group Ltd.
"Underwriters' Engagement Letter" means the letter dated July 17, 1997,
pursuant to which the Underwriters were engaged by Healthworld.
"Underwriting Agreement" means the agreement to be negotiated between
Healthworld and the Underwriters regarding the Underwriters' representation of
Healthworld in the IPO.
"U.K. Agreement of Organization" has the meaning set forth in Section
1.1.4.
"U.K. Company" has the meaning set forth in the introductory paragraphs of
this Agreement.
"U.K. Percentage" has the meaning set forth in Section 2.3.1.
"U.K. Stockholder" has the meaning set forth in the introductory paragraphs
of this Agreement.
"U.S. Agreement of Organization" has the meaning set forth in Section
1.1.1.
"U.S. Companies" has the meaning set forth in the introductory paragraphs
of this Agreement.
"U.S. Percentage" has the meaning set forth in Section 2.3.1.
"U.S. Stockholders" means Girgenti, Hughes, ▇▇▇▇▇▇ & ▇▇▇▇▇▇▇▇▇.
"U.S. Tax" means all Federal, state, local or foreign net or gross income,
gross receipts, net proceeds, sales, use, ad valorem, value added, franchise,
bank shares, withholding, payroll, employment, excise, property, deed, stamp,
alternative or add on minimum, environmental or other taxes, assessments,
duties, fees, levies or other governmental charges of any nature
-6-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
whatever, whether disputed or not, together with any interest, penalties,
additions to tax or additional amounts with respect thereto.
"Vote of a Majority in Interest of the U.S. Stockholders" means the vote,
by formal or informal meeting, in writing or otherwise, by U.S. Stockholders
having greater than 50% of the voting control of each of the U.S. Companies.
NOW, THEREFORE, in consideration of the premises and of the mutual
agreements, representations, warranties, provisions and covenants herein
contained, the parties hereto hereby agree as follows:
1 The Organization.
1.1 Organization. The Closing of this Agreement shall take place as
described in Section 4, and all of the issued share capital of the Company which
is owned by the U.K. Stockholder shall be contributed by the U.K. Stockholder to
the capital of Healthworld in exchange for the number of shares of Healthworld
Stock set forth in Section 2.3. Simultaneously with the contribution described
in the immediately preceding sentence, in exchange for shares of stock of
Healthworld:
1.1.1 the U.S. Stockholders will be contributing all of the issued and
outstanding shares of the U.S. Companies to the capital of Healthworld,
pursuant to an Agreement of Organization of even date herewith (the "U.S.
Agreement of Organization"),
1.1.2 Garnham and Moreton will be contributing all of the issued and
outstanding shares of ESP and PDM which are owned by them to the capital of
Healthworld, pursuant to separate Agreements of Organization of even date
herewith (the "Sister Company Agreements of Organization"), and
1.1.3 The U.K. Company shall, on or prior to the Closing Date,
purchase Cater's shares owned by her in MCL pursuant to a certain Joint
Venture Agreement dated May 23, 1996, and
1.1.4 ▇▇▇▇▇▇ will be contributing all of the issued and outstanding
shares of the U.K. Company which is owned by him to the capital of
Healthworld, pursuant to an Agreement of Organization of even date herewith
(the "U.K. Agreement of Organization").
The contributions made by the U.K. Stockholder pursuant to this Agreement, the
contributions made pursuant to the U.S. Agreement of Organization, the
contributions made pursuant to the Sister Company Agreements of Organization,
and the contributions of cash by the public and/or the Underwriters in
connection with the IPO shall be considered as a single integrated
-7-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
transaction intended to qualify as tax-free under Code Section 351. The Closing
will occur contemporaneously with the Pricing of the IPO, and all of the steps
of the Closing and the completion of the IPO are an integrated series of steps
in a series of transactions, none of which would have occurred without the
expectation and anticipation that the other steps will occur or will have
occurred.
1.2 Directors and Officers. At the Closing, the directors and officers of
the Company then holding office shall remain unchanged.
2 Conversion of Stock.
2.1 Manner of Conversion. The manner of converting the share capital (the
"Company Stock") of the Company owned by the U.K. Stockholder prior to the
Closing into shares of Healthworld Stock shall be as follows: At the Closing all
of the Company Stock shall, by virtue of the capital contributions described in
Section 1.1, and without any action on the part of the U.K. Stockholder,
automatically be deemed to represent the right to receive the number of shares
of Healthworld Stock set forth in the table in Section below.
2.2 Beneficial Ownership of Shares. All Healthworld Stock to be received by
the U.K. Stockholder pursuant to this Agreement shall, except for restrictions
described in Section hereof, have the same rights as all other shares of
Healthworld Stock by reason of the provisions of the Certificate of
Incorporation of Healthworld or as otherwise provided by the Delaware General
Corporation Law. All voting rights of such Healthworld Stock to be received by
the U.K. Stockholder shall be fully exercisable by the U.K. Stockholder and the
U.K. Stockholder shall not be deprived nor restricted in exercising those
rights. At the Closing, Healthworld shall have no class of capital stock issued
and outstanding other than the Healthworld Stock.
2.3 Allocation of Shares. Healthworld will issue to the U.S. Stockholders,
the U.K. Stockholder, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇ and Moreton, in the aggregate, 5,000,000
shares (the "Aggregate Number of Founder Shares") of Healthworld Stock at the
Closing. With respect to the U.S. Stockholders, who presently own one hundred
(100) shares of Healthworld Stock in the aggregate, the conversion shall be made
in such a manner as to issue to them only that number of additional shares of
Healthworld Stock which are necessary to attain the percentage of shares set
forth below. The allocation of the Aggregate Number of Founder Shares among all
of the U.S. Stockholders, the U.K. Stockholder, ▇▇▇▇▇▇, Garnham and Moreton
shall be made as follows:
2.3.1 69% of the Aggregate Number of Founder Shares shall be
allocated to the U.S. Stockholders (the "U.S. Percentage") and 31% of
the Aggregate Number of Founder Shares shall be allocated to ▇▇▇▇▇▇ and
the Contributing Minority Stockholders (the "U.K. Percentage").
-8-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
2.3.2 The number of shares of Healthworld Stock which results
from applying the U.S. Percentage against the Aggregate Number of
Founder Shares shall be divided among the U.S. Stockholders in the
following proportions:
▇▇▇▇▇▇▇▇ 63.65%
▇▇▇▇▇▇ 5.00%
▇▇▇▇▇▇ 14.06%
▇▇▇▇▇▇▇▇▇ 17.29%
-------------------------------------------
Total 100.00%
2.3.3 The number of shares of Healthworld Stock which results
from applying the U.K. Percentage against the Aggregate Number of
Founder Shares shall be divided among the U.K. Stockholder, ▇▇▇▇▇▇,
Garnham and Moreton in the following manner:
2.3.3.1 Garnham shall receive that number of shares of
Healthworld Stock having a value of (pound)1,000,000,
based on the Offering Price and utilizing the Prevailing
Conversion Rate.
2.3.3.2 The U.K. Stockholder shall receive that number of shares
of Healthworld Stock having a value of
(pound)276,448.35, based on the Offering Price and
utilizing the Prevailing Conversion Rate.
2.3.3.3 Moreton shall receive that number of shares of
Healthworld Stock having a value of (pound)53,677 based
on the Offering Price and utilizing the Prevailing
Conversion Rate.
2.3.3.4 ▇▇▇▇▇▇ shall receive the balance of the shares of
Healthworld Stock.
2.3.3.5 Cater shall not receive any shares of Healthworld Stock.
-9-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
2.3.4 No Fractional Shares. No certificates or script
representing fractional shares of Healthworld shall be issued
upon the surrender and exchange of shares. Each holder of shares
who otherwise would have been entitled to receive a fractional
share of Healthworld (after taking into account all certificates
surrendered by such holder) shall be entitled to receive, in
lieu thereof, a payment in the amount (without interest) equal
to such fractional part of a share of Healthworld, multiplied by
the offering price in the IPO and, where appropriate, utilizing
the Prevailing Conversion Rate.
3 Delivery of U.K. Company Stock and Healthworld Stock; Disclaimer of Rights.
3.1 At the Closing, the U.K. Stockholder shall deliver to
Healthworld duly executed stock transfer forms effective to transfer
into the name of Healthworld or its nominee the entire issued share
capital which he owns in the Company together with definitive
certificate(s) therefor. The U.K. Stockholder agrees to cure any
deficiencies prior to the Closing with respect to the endorsement of the
share certificate(s) or other documents of conveyance with respect to
the Company Stock or with respect to the stock transfer form
accompanying any Company Stock. At the Closing, Healthworld shall issue
in the name of the U.K. Stockholder and deliver to the U.K. Stockholder
that number of shares of Healthworld Stock which results from applying
the percentage as is set forth in Section 2.3, dated the Closing Date.
3.2 Other than the rights described in this Agreement, the U.K.
Stockholder hereby disclaims and renounces, effective as of the Closing
Date, all rights and entitlements which he has or may have had with
respect to his ownership of share capital of the Company, including
without limitation any rights which he may have had pursuant to any
shareholders agreements pertaining to the Company. No further writing or
action shall be required to effectuate this renunciation and disclaimer,
which shall take effect automatically upon the Closing of the
transactions contemplated hereunder.
4 Closing.
On the earlier of November 12, 1997 or the Pricing, the parties
shall take all actions necessary to effect the Organization, to effect the
conversion and delivery of shares referred to in Section 3 hereof and to
consummate all transactions contemplated by this Agreement. The taking of such
actions shall occur at the offices of Todtman, Nachamie, ▇▇▇▇▇▇▇ & Spizz, P.C.,
▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇. The date on which such actions occur
shall be referred to as the "Closing Date" and the consummation of the
transactions occurring on such date shall be referred to as the "Closing."
-10-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
5 Representations And Warranties of the U.K. Stockholder.
Preliminary Matters in Respect of Representations and Warranties:
Annexed hereto and made a part hereof is a disclosure schedule
(individually a "Disclosure Schedule" and collectively the "Disclosure
Schedules") for the Company, setting forth all exceptions and/or qualifications
to the representations and warranties made herein. It is understood and agreed
that any disclosure made on any Disclosure Schedule delivered pursuant hereto
shall be deemed to have been disclosed for purposes of any other Disclosure
Schedule required hereby. The U.K. Stockholder shall make a good faith effort to
cross reference disclosure, as necessary or advisable, between related
Disclosure Schedules.
The representations and warranties made herein are being made for the
benefit of Healthworld, the U.S. Stockholders, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇ and Moreton. The
U.K. Stockholder represents and warrants that all of the following
representations and warranties in this Section 5 are true with respect to the
Company at the date of this Agreement and, subject to Section 7.8 hereof, shall
be true on the Closing Date. All representations and warranties contained in
this Section 5 shall survive the Closing Date for a period of twelve (12) months
(the last day of such period being the "Expiration Date"), except that
(i) the warranties and representations set forth in Section hereof
(regarding "Taxes") shall survive until such time as the limitations
period has run for all tax periods ended on or prior to the Closing
Date, which shall be deemed to be the Expiration Date for Section 5.21;
(ii) the warranties and representations set forth in Section hereof
(regarding "Authority; Ownership"), which shall be referred to in this
Agreement as the "Absolute Representations" shall survive forever; and
(iii) solely for purposes of determining whether a claim for
indemnification under Section 11.1 hereof has been made on a timely
basis, and solely to the extent that in connection with the IPO,
Healthworld actually incurs liability under the 1933 Act, the 1934 Act,
or any other Federal or state securities laws, the representations and
warranties set forth herein shall survive until the expiration of any
applicable limitations period, which shall be deemed to be the
Expiration Date for such purposes.
5.1 Due Organization. The Company is a corporation duly incorporated under
the laws of the jurisdiction of its incorporation, and is duly authorized and
qualified under all applicable laws, regulations, ordinances and orders of
public authorities to carry on its business in the places and in the manner as
now conducted except as set forth on Schedule 5.1 or where
-11-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
the failure to be so authorized or qualified would not have a material adverse
effect on the business, operations, affairs, prospects, properties, assets or
condition (financial or otherwise), of the Company, taken as a whole (as used
herein with respect to the Company, or with respect to any other person, a
"Material Adverse Effect"). Schedule 5.1 sets forth the jurisdiction in which
the Company is incorporated and contains a list of all jurisdictions in which
the Company is authorized or qualified to do business. In all material respects,
all accounts, books, ledgers, financial and other records of whatsoever kind of
the Company have been fully, properly and accurately maintained and are up to
date, are in the possession of the Company and contain true and accurate records
of all matters required by law to be entered therein and do not contain or
reflect any material inaccuracies or discrepancies. No notice or allegation that
any of the said records is incorrect, or should be rectified, in any material
respect, has been received by the Company. The most recent minutes of the
Company, which are dated no earlier than ten business days prior to the date
hereof, affirm and ratify all prior acts of the Company, and of its officers and
directors on behalf of the Company.
Within the five (5) year period ending with the date hereof, no order has
been made or petition presented or resolution passed for the winding-up or
administration of the Company nor has any distress, execution or other process
been levied against the Company or action taken to repossess goods in the
Company's possession and the Company is not insolvent or unable to pay its debts
for the purposes of the Insolvency ▇▇▇ ▇▇▇▇.
Within the five (5) year period ending with the date hereof, no receiver,
administrative receiver or administrator has been appointed of the whole or any
material part of the assets of the Company nor is the U.K. Stockholder aware of
any circumstances likely to give rise to the appointment of any such receiver,
administrative receiver or administrator.
The Company has complied in all material respects with the provisions of
the Companies ▇▇▇ ▇▇▇▇, and all Returns, particulars, resolutions and other
documents required under the legislation to be delivered on behalf of the
Company to the Registrar of Companies in the United Kingdom have in all material
respects been properly made and delivered.
5.2 Prohibited Activities. Except as set forth on Schedule 5.2, the Company
has not, between the Balance Sheet Date and the date hereof, taken any of the
actions set forth in Section 7.3.
5.3 Capital Stock of the Company. The authorized and issued share capital
of the Company is as set forth in Schedule 5.3. Except as set forth on Schedule
5.3, all of such shares are owned free and clear of all Encumbrances and claims
of every kind. All of the issued shares of the Company have been properly issued
and allotted and are fully paid or credited as fully paid. Such shares were
offered, issued, sold and delivered by the Company in compliance with
-12-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
all applicable laws concerning the issuance of securities. None of such shares
were issued in violation of the preemptive rights of any past or present
stockholder.
5.4 Transactions in Capital Stock. Except as set forth on Schedule 5.4, the
Company has not acquired any Company Stock or any stock of any of the
Subsidiaries since January 1, 1995. Except as set forth on Schedule 5.4,
5.4.1 No person has the right (whether exercisable now or in the
future and whether contingent or not) to call for the allotment, issue,
sale, redemption or transfer of any share or loan capital of the Company
under any option or other agreement (including conversion rights and
rights of pre-preemption);
5.4.2 the Company has no obligation (contingent or otherwise) to
purchase, redeem or otherwise acquire any of its shares or any interests
therein (or of any of its Subsidiaries) or to pay any dividend or make
any distribution in respect thereof, nor do any of the Subsidiaries have
any obligation (contingent or otherwise) to purchase, redeem or
otherwise acquire any of their respective shares or any interest therein
or to pay any dividend or make any distribution in respect thereof;
5.4.3 the Company has no obligation (contingent or otherwise) to
sell any of its shares or any interests therein; and
5.4.4 neither the voting rights attaching to the shares in the
capital of the Company nor the relative ownership of shares among any of
its stockholders has been altered or changed in contemplation of the
Organization and/or the Healthworld Plan of Organization.
5.5 No Bonus Shares. Except as set forth on Schedule 5.5, none of the
shares of Company Stock was issued pursuant to awards, grants or bonuses.
5.6 Subsidiaries. Except as set forth on Schedule 5.6, the Company has no
Subsidiaries. Except as set forth in Schedule 5.6 and except for any
corporations or entities with respect to which the Company owns less than 10% of
the issued and outstanding stock, the Company does not presently own, of record
or beneficially, or control, directly or indirectly, any capital stock,
securities convertible into capital stock or any other equity interest in any
corporation, association or business entity nor is the Company, directly or
indirectly, a participant in any joint venture, partnership or other
non-corporate entity.
5.7 Predecessor Status; etc. Set forth in Schedule 5.7 is a listing of all
names of all predecessor companies of the Company, including the names of any
entities acquired by the Company (by stock purchase, merger, or otherwise) or
owned by the Company or from whom the Company previously acquired material
assets, since the date of the Company's incorporation or the date of
incorporation of any predecessor by merger or other business combination,
-13-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
whichever is earlier. Except as disclosed on Schedule 5.7, the Company has not
been, within such period of time, a Subsidiary or division of another
corporation or a part of an acquisition which was later rescinded.
5.8 Spin-off by the Company. Except as set forth on Schedule 5.8, there has
not been any sale, spin-off or split-up of material assets of either the Company
or any other person or entity that directly, or indirectly through one or more
intermediaries, controls, or is controlled by, or is under common control with,
the Company ("Affiliates") since January 1, 1995.
5.9 Financial Statements. Attached hereto as Schedule 5.9 are copies of the
following financial statements (the "Company Financial Statements") of the
Company: the Company's audited Balance Sheets as of November 30, 1996 (the "1996
Balance Sheet") and 1995 and Profit and Loss Accounts, Directors' and Auditors'
reports thereon and the notes thereto and all other documents annexed thereto
for each of the years in the two-year period ended November 30, 1996, the
unaudited management accounts of the Company which form part of the unaudited
consolidated financial statements for the period between the Balance Sheet Date
and June 30, 1997, and the consolidated unaudited balance sheet as of June 30,
1997. Such Company Financial Statements (other than the unaudited management
accounts of the Company for the period between the Balance Sheet Date and June
30, 1997, which have been prepared in accordance with U.S. generally accepted
accounting principles) have been prepared in accordance with the Companies ▇▇▇
▇▇▇▇, generally accepted accounting principles including all statements of U.K.
Standard Accounting Practice and U.K. Financial Reporting Standards applied on a
consistent basis throughout the periods indicated (except as noted thereon or on
Schedule 5.9). Except as set forth on Schedule 5.9, such Balance Sheets as of
November 30, 1996, 1995 and 1994 give a true and fair view of the assets and
liabilities and the financial position of the Company as of the dates indicated
thereon, and the Company Financial Statements give a true and fair view of the
profits and losses for the periods indicated thereon.
5.10 Liabilities and Obligations. Except (i) as set forth on Schedule
5.10, (ii) for liabilities to the extent reflected or reserved against in the
1996 Balance Sheet and (iii) for obligations required by this Agreement, since
the Balance Sheet Date the Company has not incurred any material liabilities of
any kind, character and description, whether accrued, absolute, secured or
unsecured, contingent or otherwise, other than liabilities incurred in the
ordinary course of business. Schedule 5.10 also includes, in the case of those
contingent liabilities related to pending or threatened litigation, or other
liabilities which are not fixed or otherwise accrued or reserved, a good faith
and reasonable estimate of the maximum amount which may be payable. For each
such contingent liability or liability for which the amount is not fixed or is
contested, Schedule 5.10 includes the following information:
5.10.1 a summary description of the liability together with the
following:
-14-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
5.10.1.1 copies of all relevant documentation relating
thereto;
5.10.1.2 amounts claimed and any other action or relief
sought; and
5.10.1.3 name of claimant and all other parties to the
claim, suit or proceeding;
5.10.2 the name of each court or agency before which such
claim, suit or proceeding is pending;
5.10.3 the date such claim, suit or proceeding was instituted;
and
5.10.4 a good faith and reasonable estimate of the maximum
amount, if any, which is likely to become payable with respect to each
such liability. If no estimate is provided, the estimate shall for
purposes of this Agreement be deemed to be zero.
5.11 Accounts and Notes Receivable. Schedule 5.11 includes an accurate list
of the accounts and notes receivable of the Company, as of the Balance Sheet
Date, including any such amounts which are not reflected in the balance sheet as
of the Balance Sheet Date, and including receivables from and advances to
employees and the U.K. Stockholder. The U.K. Stockholder shall use commercially
reasonable efforts to cause the Company to provide to Healthworld, not later
than the Closing Date, (i) an accurate list of all receivables obtained
subsequent to the Balance Sheet Date and (ii) an aging of all accounts and notes
receivable showing amounts due in 30 day aging categories. Such list and such
aging report (the "A/R Aging Reports") shall be current as of the end of the
calendar month which immediately precedes the Closing Date.
5.12 Permits and Intangibles. The Company holds all licenses, permits and
other governmental authorizations the absence of any of which could have a
Material Adverse Effect on its business. Schedule 5.12 contains an accurate list
and summary description of all such licenses, permits and other governmental
authorizations, including permits, titles (including motor vehicle titles and
current registrations), licenses, certificates, trademarks, tradenames, patents,
patent applications and copyrights owned or held by the Company (including
interests in software or other technology systems, programs and intellectual
property other than software generally available in retail markets). To the
knowledge of the U.K. Stockholder, (a) the licenses, permits and other
governmental authorizations listed on Schedule 5.12 are valid, and (b) the
Company has not received any notice that any governmental authority intends to
cancel, terminate or not renew any such license, permit or other governmental
authorization. The Company has conducted and is conducting its business in
compliance in all material respects with the requirements, standards, criteria
and conditions set forth in the licenses, permits and other governmental
authorizations listed on Schedule 5.12 and is not in violation of any of the
foregoing except where such non-compliance or violation would not have a
Material Adverse
-15-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
Effect on the Company. Except as specifically provided in Schedule 5.12, the
transactions contemplated by this Agreement will not result in a material
default under or a material breach or violation of, or materially adversely
affect the rights and benefits afforded to the Company by, any such licenses,
permits or government authorizations.
5.13 Environmental Matters. Except as set forth on Schedule 5.13, the
Company has, in all material respects, complied with and is in compliance with
all material national, state, local and, so far as it is required, foreign
statutes, laws, ordinances, regulations, rules, notices, permits, judgments,
orders and decrees applicable to it or any of its respective properties, assets,
operations and businesses relating to environmental protection (collectively
"Environmental Laws"). The Company has no actual or contingent liability in
connection with any Environmental Laws which would have a Material Adverse
Effect.
5.14 Personal Property. Schedule 5.14 contains an accurate list of
5.14.1 all personal property with a value in excess of
(pound)1,250 included (or that will be included) in "depreciable plant,
property and equipment" on the 1996 Balance Sheet,
5.14.2 all other personal property owned by the Company with a
value in excess of (pound)1,250 as of the Balance Sheet Date and
acquired since the Balance Sheet Date and
5.14.3 all leases and agreements in respect of personal property
providing for payments of greater than (pound)625 per annum,
including, (1) true, complete and correct copies of all such leases and (2) an
indication as to which assets are currently owned, or were formerly owned, by
the U.K. Stockholder, relatives of the U.K. Stockholder, or Affiliates of the
Company. Except as set forth on Schedule 5.14,
5.14.4 all personal property used by the Company in its business
is either owned by the Company or leased by the Company pursuant to a
lease included on Schedule 5.14,
5.14.5 all of the personal property listed on Schedule 5.14 is
in good working order and condition, ordinary wear and tear excepted and
5.14.6 all leases and agreements included on Schedule 5.14 are
in full force and effect and constitute valid and binding agreements of
the parties (and their successors) thereto in accordance with their
respective terms.
5.15 Significant Customers; Material Contracts and Commitments. Schedule
5.15 contains an accurate list of all significant customers, it being understood
and agreed that a "significant customer," for purposes of this Section 5.15,
means any customer (or person or
-16-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
entity) representing 5% or more of the Company's annual revenues for the
one-year period ending with the Balance Sheet Date. Except to the extent set
forth on Schedule 5.15, none of the Company's significant customers have
canceled or substantially reduced or, to the knowledge of the Company, are
currently attempting or threatening to cancel a contract or substantially reduce
utilization of the services provided by the Company. Schedule 5.15 contains a
list of all material contracts, commitments and similar agreements to which the
Company is a party or by which it or any of its properties are bound (including,
but not limited to, contracts with significant customers, joint venture or
partnership agreements, contracts with any labor organizations, strategic
alliances and options to purchase land), other than agreements listed on
Schedule 5.10, 5.14 or 5.16, and in each case the U.K. Stockholder has delivered
true, complete and correct copies of such agreements to Healthworld. The Company
has complied with all material commitments and obligations pertaining to it, and
is not in default in any material respect under any contracts or agreements
listed on Schedule 5.15 and no notice of default under any such contract or
agreement has been received which default would have a Material Adverse Effect
on the Company. Also included in Schedule 5.15 is a summary description of all
material plans or projects involving the opening of new operations, expansion of
existing operations, or the acquisition of any personal property, business or
assets.
5.16 Real Property. Schedule 5.16 includes an accurate list of all real
property owned or leased by the Company as of the Balance Sheet Date and
acquired since the Balance Sheet Date, and all other real property, if any, used
by the Company in the conduct of its business. The Company has good and
insurable title to the real property owned by it, subject to no mortgage,
pledge, lien, conditional sales agreement, encumbrance or charge, except as set
forth in Schedule 5.16. The U.K. Stockholder has delivered true, complete and
correct copies of all leases and agreements in respect of real property leased
by the Company. Schedule 5.16 indicates which such properties, if any, are
currently owned, or were formerly owned, by any Affiliates, by the U.K.
Stockholder, by any relative of the U.K. Stockholder or by any entity that
directly, or indirectly through one or more intermediaries, is controlled by the
U.K. Stockholder or any of his relatives. All of such leases included on
Schedule 5.16 are in full force and effect and constitute valid and binding
agreements of the parties (and their successors) thereto in accordance with
their respective terms.
5.17 Insurance. Schedule 5.17 includes
5.17.1 an accurate list as of the Balance Sheet Date of all
insurance policies carried by the Company; and
5.17.2 an accurate list of all insurance loss runs or workers
compensation claims received for the past three (3) policy years.
-17-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
The U.K. Stockholder has delivered to Healthworld true, complete and correct
copies of all insurance policies currently in effect. Such insurance policies
evidence all of the insurance that the Company is required to carry pursuant to
all of its contracts and other agreements and pursuant to all applicable laws.
All of such insurance policies are currently in full force and effect and shall
remain in full force and effect through the Closing Date. Since January 1, 1995,
no insurance carried by the Company has been canceled by the insurer and the
Company has not been denied any requested coverage.
5.18 Compensation; Employment Agreements; Organized Labor Matters.
5.18.1 Schedule 5.18 contains an accurate list showing all
officers, directors and Key Employees of the Company, listing all
employment agreements with such officers, directors and Key Employees
and the rate of compensation (and the portions thereof attributable to
salary, bonus and other compensation, respectively) of each of such
persons as of the Balance Sheet Date and the date hereof. The U.K.
Stockholder has delivered true, complete and correct copies of any
employment agreements for persons listed on Schedule 5.18.
5.18.2 Except as set forth in Schedule 5.18, since the Balance
Sheet Date, there have been no increases in the compensation payable or
any special bonuses to any officer, director, Key Employee or other
employee, except ordinary salary increases implemented on a basis
consistent with past practices.
5.18.3 Except as set forth on Schedule 5.18, the Company is not
bound by or subject to (and none of its respective assets or properties
is bound by or subject to) any arrangement with any labor union, no
employees of the Company are represented by any labor union or covered
by any collective bargaining agreement, no campaign to establish such
representation is in progress and there is no pending or, to the best of
the U.K. Stockholder's knowledge, any threatened labor dispute involving
the Company and any group of its employees nor has the Company
experienced any labor interruptions over the past three years.
5.18.4 The U.K. Stockholder believes that the Company's
relationship with its employees is good.
5.18.5 Except as set forth in Schedule 5.18, all appropriate
notices have been issued under all statutes, regulations and codes of
conduct relevant to the relations between the Company and its employees
or any recognized trade union, except for notices the absence of which
would not have a Material Adverse Effect upon the Company, and the
Company has maintained adequate and suitable records regarding the
service of its employees.
5.18.6 Except as set forth in Schedule 5.18, the Company has not
entered into any currently effective collective agreement or arrangement
(whether legally binding or not)
-18-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
with a trade union, works counsel, staff association or association of
trade unions or other body representing any of its employees nor has it
done within the two-year period ending with the date hereof any act
which might reasonably be construed as recognition of such a union or
body.
5.18.7 Schedule 5.18 contains a listing of each written
agreement and a summary of the terms and conditions of each unwritten
agreement pursuant to which any officers, directors, Key Employees and
Key Consultants of the Company (and their dependents) are engaged. The
summary of unwritten agreements shall include, without limitation,
details of all participation, profit sharing, incentive, bonus,
commission, share option, medical, permanent health insurance, directors
and officers insurance, travel, car, redundancy and other benefit
schemes, arrangements and understandings and whether legally binding
upon the Company or not and of all Key Consultant Agreements with the
Company which are in place now or, to the extent now known, will be in
place at the Closing.
5.18.8 Except as set forth in Schedule 5.18, since January 1,
1997, there have been no increases in the emoluments payable to or
changes in the terms of service of any officer, director or Key Employee
of the Company.
5.18.9 Except as set forth in Schedule 5.18, there is not in
existence any contract of employment with officers, directors or
employees of the Company (or any contract for services with any
individual) which cannot be terminated by three months notice or less or
(where such a contract has not been reduced to writing) by reasonable
notice without giving rise to a claim for damages or compensation (other
than a statutory redundancy payment or statutory compensation for unfair
dismissal).
5.18.10 Except as set forth in Schedule 5.18, no promise has
been made and the Company is not obliged to increase the emoluments
payable to or to vary the terms of service of any of its directors,
other officers and employees.
5.18.11 Except as set forth in Schedule 5.18, there are not, nor
will there be at Closing, outstanding offers of employment or
consultancy made by the Company and there is no one who has accepted an
offer of employment or consultancy made by the Company but who has not
yet taken up that employment or consultancy.
5.18.12 Except as set forth in Schedule 5.18, neither the
Company nor any of its employees is involved in any industrial or trade
dispute and there are no facts known to the Company which might suggest
that there may be any trade union or industrial dispute involving the
Company or that the disposition of the Company Stock may lead to any
trade union or industrial dispute.
-19-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
5.18.13 Except as set forth in Schedule 5.18, there are no
amounts owing or promised to any present or former directors, employees
or consultants of the Company other than remuneration accrued due or for
reimbursement of business expenses and no directors, employees or
consultants of the Company have given or been given notice terminating
their contracts of employment or consultancy.
5.18.14 Except as set forth in Schedule 5.18, no claim has been
made and no liability has been incurred by the Company (a) for breach of
any contract of service or for redundancy payments (including protective
awards) or for compensation for wrongful dismissal or unfair dismissal
or for failure to comply with any order for the reinstatement or
re-engagement of any employee or for the actual or proposed termination
or suspension of employment or variation of any terms of employment of
any present or former employee of the Company or (b) in respect of any
payment to be made or benefit to be provided to any present or former
director, employee or consultant of the Company in connection with the
consummation of the transactions contemplated hereby, or (c) for the
breach of or the actual or proposed termination or variation of any
contract for services or consultancy agreement for any present or former
consultant to the Company.
5.18.15 Except as set forth in Schedule 5.18, no gratuitous
payment has been made or promised by the Company in connection with the
disposition of the Company Stock or in connection with the actual or
proposed termination or suspension of employment or variation of any
contract of employment of any present or former director or employee or
in connection with the proposed termination or suspension or variation
of any contract for services or consultancy agreement.
5.18.16 Except as set forth in Schedule 5.18, there are no
material claims pending or, to the knowledge of the U.K. Stockholder,
threatened against the Company:
5.18.16.1 by a present or former employee, director,
consultant or third party, in respect of an accident or injury
which is not fully covered by insurance; or
5.18.16.2 by a present or former employee, director or
consultant in relation to his terms and conditions of employment
or (as the case may be) consultancy.
5.18.17 Except as set forth in Schedule 5.18, the Company has in
relation to each of its employees (and so far as relevant to each of its
former employees and persons seeking employment) complied with, in all
material respects:
-20-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
5.18.17.1 all laws and codes of conduct and practice
relevant to the relations between it and its employees,
prospective employees or any trade union;
5.18.17.2 all collective agreements and customs and
practices for the time being dealing with the terms and
conditions of service of its employees; and
5.18.17.3 all relevant orders, declarations and awards
made under any relevant law or code of conduct and practice
affecting the conditions of service of its employees.
5.18.18 Except as set forth in Schedule 5.18, no Key Employee
has ceased to be employed by the Company (other than through death or
retirement at normal retirement age) during the twelve months prior to
the date hereof and the Company has no reason to believe that such
employees intend or are likely to leave their employment otherwise than
through retirement as aforesaid within the twelve months following the
Closing.
5.18.19 Except as set forth in Schedule 5.18, there are no
agreements, arrangements or schemes in operation by or in relation to
the Company pursuant to which any of its employees or officers and/or
former employees or officers and/or their relatives and dependents is
entitled to shares of capital stock or a commission or remuneration of
any kind calculated by reference in whole or in part to turnover,
profits or sales.
5.18.20 Except as set forth in Schedules 5.18 or 5.19 or as
provided for in the 1996 Balance Sheet, there is no liability whatsoever
to make payment to or for the benefit of any director or employee or
ex-director or ex-employee or the wife or widow or any other relative of
any director, ex-director, employee or ex-employee of the Company in
respect of past service, retirement, death or disability by way of
pension contribution, pension, retirement benefit lump sum, gratuity or
otherwise.
5.18.21 Except as set forth in Schedule 5.18, the Company has
not within a period of one year preceding the date of this Agreement
given notice of any redundancies to the United Kingdom Secretary of
State or started consultations with any independent trade union or
association of unions.
5.19 Employee Benefits. Except as set forth in Schedule 5.19, the Company
has no superannuation fund, retirement benefit or other pension schemes or
arrangements. In respect of any such funds, schemes or arrangements which are
disclosed in Schedule 5.19 ("Disclosed Schemes") the Company has no unfunded
contingent obligations and any such funds, schemes or arrangements which are
funded are solvent and are so funded at a level which a prudent
-21-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
employer acting on actuarial advice would consider as being adequate to secure
the benefits which may be payable in respect of service prior to the Closing and
(insofar as the provision of any pension is concerned) having regard to probable
future salary increases, or in connection with which the Company is to become or
may become liable to make any payment and no undertakings or assurances have
been given to the employees of the Company as to the continuance or introduction
or increase or improvement of any pension rights or entitlement which the
Company and/or Healthworld would be required to implement in accordance with
good industrial relations practice and whether or not there is any legal
obligation so to do.
5.20 Conformity with Law; Litigation. Except to the extent set forth on
Schedule 5.10 or 5.13, the Company is not in violation or contravention of any
law or regulation or any order of any court or national, state, municipal or
other governmental department, commission, board, bureau, agency or
instrumentality having jurisdiction over any of them which would have a Material
Adverse Effect; and except to the extent set forth on Schedule 5.10 or 5.13,
there are no material claims, actions, suits or proceedings, commenced or, to
the knowledge of the Company, threatened, against or affecting the Company, at
law or in equity, or before or by any national, state, municipal or other
governmental department, commission, board, bureau, agency or instrumentality
having jurisdiction over any of them and no notice of any such claim, action,
suit or proceeding, whether pending or threatened, has been received. The
Company has conducted and is conducting its business in compliance, in all
material respects, with the requirements, standards, criteria and conditions set
forth in applicable national, state and local statutes, ordinances, permits,
licenses, orders, approvals, variances, rules and regulations, including all
such permits, licenses, orders and other governmental approvals set forth on
Schedules 5.12 and 5.13, and is not in violation of any of the foregoing which
might have a Material Adverse Effect.
5.21 Taxes. Except as set forth in Schedule 5.21:
5.21.1 the provisions for Taxation, including provisions for
deferred tax included in the Financial Statements, have been made in
accordance with generally accepted accounting principles and will be
sufficient (on the basis of the rates of tax current at the date of this
Agreement) to cover all Taxation for which the Company was at the
Balance Sheet Date liable or may after that date become or have become
liable for any period ended on or before the Balance Sheet Date and in
particular (but without prejudice to the generality of the foregoing)
will be sufficient to cover such Taxation on or in respect of or by
reference to any profit, gains or income (including deemed profits gains
or income) for any period ended on or before the Balance Sheet Date.
5.22.2 the Company has duly and punctually paid all Taxation to
the extent that the same ought to have been paid and is under no
liability to pay any fine, penalty or interest or to give any security
in connection therewith.
-22-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
5.21.3 the Company has made under deduction of Taxation all
payments to any person which ought to have been made under deduction of
Taxation (with particular reference to Sections 134, 347 to 350 and 524
of the Taxes Act) and has (if required by law to do so) accounted to the
Inland Revenue for the Taxation so deducted;
5.21.4 the Company has in all material respects properly
operated the P.A.Y.E. system, and all National Insurance Contributions
and sums payable to the Inland Revenue and the Department of Social
Security under the P.A.Y.E. system (including ex gratia payments and
compensation for loss of office) (Section 148 of the Taxes Act)
(Sections 153 to 168G of the Taxes Act) due and payable by the Company
up to the date hereof have been paid;
5.21.5 the Company has duly paid all Taxation shown to be due to
the Inland Revenue by all Returns required to be made under Schedule 13
to the Taxes Act (advance corporation tax);
5.21.6 the Company has correctly operated a statutory sick pay
scheme in accordance with the provisions of the United Kingdom Social
Security Contributions and Benefits ▇▇▇ ▇▇▇▇;
5.21.7 prior to the Closing all documents to which the Company
is a party and all documents in the enforcement of which the Company may
be interested or to the production of which the Company is entitled
which are necessary to establish the title of the Company to any asset
and which attract stamp duty in the United Kingdom or elsewhere have
been properly stamped and the appropriate stamp duty has been paid and
all duty payable in respect of the capital of the Company has been paid
and the Company has duly paid any stamp duty reserve tax for which it
has at any time been liable.
5.21.8 the Company has and at Closing will have duly and
punctually made all Returns, given all notices and accounts and supplied
all other information which ought to have been made given or supplied
for the purpose of and in respect of Taxation in the United Kingdom and,
so far as the U.K. Stockholder is aware, elsewhere, to the Inland
Revenue, H.M. Commissioners of Customs and Excise or to any other
governmental authority (including any governmental authority of a
foreign jurisdiction) and has and at Closing will have kept and
maintained all records, invoices and other documents which ought to have
been kept or maintained for such purposes and:
5.21.8.1 all such information, Returns, accounts,
notices, records, invoices and other documents were, are, and at
the Closing will be, in all material respects, up-to-date,
accurate, and made on the proper basis and are not, nor, is
likely to be,
-23-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
the subject of any dispute with the Inland Revenue, H.M.
Commissioners of Customs and Excise or other appropriate
authorities concerned;
5.21.8.2 the Company has not within the preceding seven
years been the subject of a back duty, PAYE or other audit or
investigation by the Inland Revenue or H.M. Commissioners of
Customs and Excise (or other similar authority outside the
United Kingdom);
5.21.8.3 all clearances and consents obtained from H.M.
Treasury, the Inland Revenue, H.M. Commissioners of Customs and
Excise or other authority whether in the United Kingdom or
elsewhere have been obtained after full, complete and accurate
disclosure of all material facts and considerations and no such
clearances or consent is, to the knowledge of the U.K.
Stockholder, liable to be withdrawn, modified or rendered void
and, to the knowledge of the U.K. Stockholder, all such
clearances and consents have been disclosed to Healthworld.
5.22 No Violations. Neither the Company nor, to the knowledge of the
Company, any other party thereto, is in default in any material respect under
any lease, instrument, agreement, license, or permit set forth on Schedule 5.12,
5.13, 5.14, 5.15 or 5.16, or any other material agreement to which it is a party
or by which its properties are bound (the "Material Documents"). Except as set
forth in Schedule 5.22,
5.22.1 the rights and benefits of the Company under the Material
Documents will not be materially adversely affected by the transactions
contemplated hereby;
5.22.2 the execution of this Agreement and the performance of
the obligations hereunder and the consummation of the transactions
contemplated hereby will not result in any material violation or breach
or constitute a material default under, any of the terms or provisions
of the Material Documents or the Company's Memorandum and Articles of
Association.
5.22.3 none of the Material Documents requires notice to or the
consent or approval of, any governmental agency or other third party
with respect to any of the transactions contemplated hereby in order to
remain in full force and effect; and
5.22.4 consummation of the transactions contemplated hereby will
not give rise to any right to termination, cancellation or acceleration
or loss of any material right or benefit.
-24-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
Except as set forth on Schedule 5.22, none of the Material Documents prohibits
the use or publication by Healthworld or any of its Subsidiaries of the name of
any other party to such Material Document, and none of the Material Documents
prohibits or restricts the Company from freely providing services to any other
customer or potential customer of the Company, Healthworld, or any of their
respective Subsidiaries.
5.23 Government Contracts. Except as set forth on Schedule , the Company is
not now a party to any governmental contract subject to price redetermination or
renegotiation.
5.24 Absence of Changes. Since the Balance Sheet Date, except as set forth
on Schedule , there has not been:
5.24.1 any Material Adverse Effect on the Company;
5.24.2 any damage, destruction or loss (whether or not covered
by insurance) materially adversely affecting the properties or business
of the Company;
5.24.3 any change in the authorized capital of the Company or
its outstanding securities or any change in its ownership interests or
any grant of any options, warrants, calls, conversion rights or
commitments;
5.24.4 any declaration or payment of any dividend or
distribution in respect of the shares in the capital of the Company or
any direct or indirect redemption, purchase or other acquisition of any
of the shares in the capital of the Company;
5.24.5 any increase in the compensation, bonus, sales
commissions or fee arrangement payable or to become payable by the
Company to any of its officers, directors, stockholders, employees,
consultants or agents, except for ordinary and customary bonuses and
salary increases for employees in accordance with past practice;
5.24.6 any work interruptions, labor grievances or claims filed,
or any other event or condition of any character materially adversely
affecting the business of the Company;
5.24.7 any sale or transfer, or any agreement to sell or
transfer, any material assets, property or rights of the Company to any
person, including, without limitation, the U.K. Stockholder and his
affiliates;
5.24.8 any cancellation, or agreement to cancel, any material
indebtedness or other obligation owing to the Company, including without
limitation any material indebtedness or obligation of the U.K.
Stockholder or any affiliate thereof;
-25-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
5.24.9 any plan, agreement or arrangement granting any
preferential rights to purchase or acquire any interest in any of the
assets, property or rights of the Company or requiring consent of any
party to the transfer and assignment of any such assets, property or
rights;
5.24.10 any purchase or acquisition of, or agreement, plan or
arrangement to purchase or acquire, any property, rights or assets
outside of the ordinary course of the Company's business;
5.24.11 any waiver of any material rights or claims of the
Company;
5.24.12 any material breach, amendment or termination of any
material contract, agreement, license, permit or other right to which
the Company is a party;
5.24.13 any transaction by the Company outside the ordinary
course of its respective businesses;
5.24.14 any cancellation or termination of a material contract
with a customer or client prior to the scheduled termination date; or
5.24.15 any other distribution to or for the benefit of the
U.K. Stockholder of property or assets by the Company.
5.25 Deposit Accounts; Powers of Attorney. Schedule contains an accurate
schedule as of the date of the Agreement of:
5.25.1 the name of each financial institution in which the
Company has accounts or safe deposit boxes;
5.21.2 the names in which the accounts or boxes are held;
5.25.3 the type of account and account number; and
5.25.4 the name of each person authorized to draw thereon or
have access thereto.
Schedule 5.25 also sets forth the name of each person, corporation, firm or
other entity holding a general or special power of attorney from the Company and
a description of the terms of such power.
-26-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
5.26 Brokers and Agents. Except as disclosed on Schedule 5.26, the U.K.
Stockholder did not employ any broker or agent in connection with this
transaction.
5.27 Relations with Governments. Except for political contributions made in
a lawful manner which, in the aggregate, do not exceed (pound)6,250 per year for
each year in which the U.K. Stockholder has been a stockholder of the Company,
the Company has not made, offered or agreed to offer anything of value to any
governmental official, political party or candidate for government office. If
political contributions made by the Company have exceeded (pound)6,250 per year
for each year in which the U.K. Stockholder has been a stockholder of the
Company, each contribution in the amount of (pound)3,125 or more shall be
described on Schedule 5.27.
5.28 Disclosure.
5.28.1 If, on or prior to the 25th day after the date of the
final prospectus of Healthworld utilized in connection with the IPO, the
U.K. Stockholder becomes aware of any fact or circumstance which would
change (or, if after the Closing Date, would have changed) a
representation or warranty of the U.K. Stockholder in this Agreement or
would affect any document delivered pursuant hereto in any material
respect, the U.K. Stockholder shall immediately give notice of such fact
or circumstance to Healthworld. However, subject to the provisions of
Section 7.8, such notification shall not relieve the U.K. Stockholder of
his obligations under this Agreement.
5.28.2 The U.K. Stockholder acknowledges and agrees:
5.28.2.1 that there exists no firm commitment, binding
agreement, or promise or other assurance of any kind, whether
express or implied, oral or written, that a Registration
Statement will become effective or that the IPO pursuant thereto
will occur at a particular price or within a particular range of
prices or occur at all;
5.28.2.2 that neither Healthworld nor any of its
officers, directors, agents or representatives nor any
Underwriter (other than as provided in the Underwriting
Agreement) shall have any liability to the Company, the U.K.
Stockholder or any other person affiliated or associated with
the Company for any failure of the Registration Statement to
become effective, the IPO to occur at a particular price or
within a particular range of prices or to occur at all; and
-27-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
5.28.2.3 that the decision of U.K. Stockholder to enter
into this Agreement, has been or will be made independent of,
and without reliance upon, any statements, opinions or other
communications, or due diligence investigations which have been
or will be made or performed by any prospective underwriters,
relative to Healthworld or the IPO.
5.29 Authority; Ownership. The U.K. Stockholder has the full legal right,
power and authority to enter into this Agreement. The U.K. Stockholder is the
registered and beneficial owner with full title guarantee of the shares of the
Company Stock identified in Schedule 5.3 as being owned by the U.K. Stockholder
and neither owns nor has any right, title or interest in or to any other Company
Stock, and, except as set forth on Schedule 5.29, such Company Stock is owned
free and clear of all Encumbrances and claims of every kind.
5.30 Preemptive Rights. The U.K. Stockholder does not have, or hereby
waives, any preemptive or other right to acquire shares of Company Stock or
Healthworld Stock that the U.K. Stockholder has or may have had other than
rights of the U.K. Stockholder to acquire Healthworld Stock pursuant to this
Agreement or any option granted by Healthworld.
5.31 No Intention to Dispose of Healthworld Stock. The U.K. Stockholder is
not under any binding commitment or contract to sell, exchange or otherwise
dispose of shares of Healthworld Stock to be received in connection with the
Organization.
6 Representations of Healthworld.
Healthworld represents and warrants that all of the following
representations and warranties in this Section 6 are true at the date of this
Agreement and, subject to Section 7.8 hereof, shall be true on the Closing Date.
All such representations and warranties shall survive the Closing Date for a
period of twelve (12) months (the last day of such period being the "Expiration
Date"), except that, solely for purposes of determining whether a claim for
indemnification under Section hereof has been made on a timely basis and solely
to the extent that in connection with the IPO any person claiming
indemnification from Healthworld hereunder actually incurs liability under the
1933 Act, the 1934 Act, or any other Federal or state securities laws, the
representations and warranties set forth herein shall survive until the
expiration of any applicable limitations period, which shall be deemed to be the
Expiration Date for such purposes.
6.1 Due Organization. Healthworld is a corporation duly organized, validly
existing and in good standing under the laws of the state of Delaware, and is
duly authorized and qualified to do business under all applicable laws,
regulations, ordinances and orders of public authorities to carry on its
business in the places and in the manner as contemplated.
-28-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
6.2 Authorization. The representatives of Healthworld executing this
Agreement have the authority to enter into and bind Healthworld to the terms of
this Agreement. Healthworld has the full legal right, power and authority to
enter into this Agreement.
6.3 Capital Stock of Healthworld. The authorized capital stock of
Healthworld is as set forth in Schedule 6.3. All of the issued and outstanding
shares of the capital stock of Healthworld are owned by the U.S. Stockholders in
the amounts set forth in Schedule 6.3. All of such shares are owned free and
clear of all Encumbrances and claims of every kind. All of the issued and
outstanding shares of the capital stock of Healthworld have been duly authorized
and validly issued and are fully paid and nonassessable. Such shares were
offered, issued, sold and delivered by Healthworld in compliance with all
applicable state and Federal laws concerning the issuance of securities.
6.4 Transactions in Capital Stock. Except for the obligations under the
agreements which form a part of the Healthworld Plan of Organization or the
obligations which will arise under the Underwriting Agreement, no option,
warrant, call, conversion right or commitment of any kind exists which obligates
Healthworld to issue any of its authorized but unissued capital stock, and
Healthworld has no obligation (contingent or otherwise) to purchase, redeem or
otherwise acquire any of its equity securities or any interests therein or to
pay any dividend or make any distribution in respect thereof. At the time of
issuance thereof, the Healthworld Stock to be delivered to the U.K. Stockholder
pursuant to this Agreement will constitute valid and legally issued shares of
Healthworld, fully paid and nonassessable. The shares of Healthworld Stock to be
issued to the U.K. Stockholder pursuant to this Agreement will not be registered
under the 1933 Act, except as provided in Section 15 hereof.
6.5 Liabilities and Obligations. Healthworld does not have any liabilities,
contingent or otherwise, except as set forth in or contemplated by this
Agreement and the other agreements forming a part of the Healthworld Plan of
Organization, including without limitation the Underwriting Agreement, for fees
incurred in connection with the transactions contemplated hereby and thereby,
and any liabilities and obligations which may exist under the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇
Employment Agreement and the Healthworld License Agreement, copies of which are
annexed to Schedule 6.5.
6.6 Conformity with Law; Litigation. Healthworld is not in violation of any
law or regulation or any order of any court or Federal, state, municipal or
other governmental department, commission, board, bureau, agency or
instrumentality having jurisdiction over it which would have a Material Adverse
Effect; and there are no material claims, actions, suits or proceedings pending
or, to the knowledge of Healthworld, threatened against or affecting
Healthworld, at law or in equity, or before or by any Federal, state, municipal
or other governmental department, commission, board, bureau, agency or
instrumentality having
-29-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
jurisdiction over it and no notice of any claim, action, suit or proceeding,
whether pending or threatened, has been received. Healthworld is not in
violation of its certificate of incorporation, its by-laws or any other
corporate governing instrument.
6.7 Validity of Obligations. The execution and delivery of this Agreement
by Healthworld and the performance of the transactions contemplated herein have
been duly and validly authorized by the Board of Directors of Healthworld. This
Agreement has been duly and validly authorized by all necessary corporate action
and is a legal, valid and binding obligation of Healthworld.
6.8 Limited Business Conducted Healthworld was formed on September 12, 1996
solely for the purpose of entering into and consummating the Healthworld Plan of
Organization. Healthworld has not filed any Returns or extension requests in
respect of Tax. Healthworld has not since its formation conducted any business,
acquired any assets, incurred any liabilities or entered into any agreements,
except Healthworld has entered into the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Employment Agreement, the
Healthworld License Agreement and has engaged in other limited startup
activities. It is anticipated that prior to the Closing, Healthworld will adopt
a Stock Option Plan; however, Healthworld covenants that no options will be
granted before the Registration Statement is declared effective by the SEC.
7 Covenants Prior to Closing.
7.1 Access and Cooperation; Due Diligence. Between the date of this
Agreement and the Closing Date, the U.K. Stockholder will use commercially
reasonable efforts to cause the Company to afford to the U.S. Stockholder
reasonable access to all of the Company's sites, properties, books and records
during normal business hours and will furnish such additional financial and
operating data and other information as to the business and properties of the
Company as may from time to time be reasonably requested. The U.K. Stockholder
will cooperate, and will use commercially reasonable efforts to cause the
Company to cooperate, in the preparation of any documents or other material
which may be reasonably required in connection with any documents or materials
required by this Agreement. The U.K. Stockholder and the Company will treat all
information obtained in connection with the negotiation and performance of this
Agreement or the due diligence investigations conducted as confidential in
accordance with the provisions of Section 13.2 hereof.
7.2 Conduct of Business Pending Closing. Between the date of this Agreement
and the Closing Date, the U.K. Stockholder shall use commercially reasonable
efforts to cause the Company to, except as set forth on Schedule 7.2 of its
respective Disclosure Schedule:
-30-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
7.2.1 carry on its respective businesses in substantially the
same manner as it has heretofore been conducted and not introduce any
material new method of management, operation or accounting;
7.2.2 maintain, in all material respects, its respective
properties and facilities, including those held under leases, in as good
working order and condition as at present, ordinary wear and tear
excepted;
7.2.3 perform in all material respects all of its respective
obligations under agreements relating to or affecting its respective
assets, properties or rights;
7.2.4 keep in full force and effect present insurance policies
or other comparable insurance coverage;
7.2.5 use its reasonable best efforts to maintain and preserve
its business organization intact, retain its respective present key
employees and maintain its respective relationships with suppliers,
customers and others having business relations with the Company;
7.2.6 maintain compliance with all material permits, laws, rules
and regulations, consent orders, and all other orders of applicable
courts, regulatory agencies and similar governmental authorities;
7.2.7 maintain present debt and lease instruments and not enter
into new or amended debt or lease instruments, except in the ordinary
course of business and except as may be reasonably necessary to
effectuate the IPO; and
7.2.8 maintain or reduce present salaries and commission levels
for all officers, directors, employees and agents except for ordinary
and customary bonus and salary increases for employees in accordance
with past practices.
7.3 Prohibited Activities. Except as disclosed on Schedule 7.3 or as
otherwise contemplated by this Agreement, between the date hereof and the
Closing Date, the U.K. Stockholder will not permit the Company to:
7.3.1 make any change in its Memorandum and Articles of
Association;
7.3.2 issue any securities, options, warrants, calls, conversion
rights or commitments relating to its securities of any kind other than
in connection with the exercise of options or warrants listed in
Schedule 5.4;
-31-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
7.3.3 declare or pay any dividend, or make any distribution in
respect of its shares whether now or hereafter outstanding, or purchase,
redeem or otherwise acquire or retire for value any shares;
7.3.4 enter into any contract or commitment or incur or agree to
incur any liability or make any capital expenditures, except if it
involves an amount not in excess of (pound)6,250 and except if it
involves the performance of services in the ordinary course of business;
7.3.5 create, assume or permit to exist any mortgage, pledge or
other lien or encumbrance upon any assets or properties whether now
owned or hereafter acquired, except:
7.3.5.1 with respect to purchase money liens incurred in
connection with the acquisition of equipment
with an aggregate cost not in excess of
(pound)6,250 necessary or desirable for the
conduct of the businesses of the Company,
7.3.5.2 liens for taxes either not yet due or being
contested in good faith and by appropriate
proceedings (and for which contested taxes
adequate reserves have been established and are
being maintained) or
7.3.5.3 materialmen's, mechanics', workers',
repairmen's, employees' or other like liens
arising in the ordinary course of business, or
7.3.5.4 liens set forth on Schedule 5.10 hereto;
7.3.6 sell, assign, lease or otherwise transfer or dispose of
any property or equipment except in the ordinary course of business;
7.3.7 negotiate for the acquisition of any business or the
start-up of any new business;
7.3.8 merge or consolidate or agree to merge or consolidate with
or into any other corporation;
7.3.9 waive any material rights or claims of the Company;
provided that the Company may negotiate and adjust bills in the course
of good faith disputes with customers in a manner consistent with past
practice, provided, further, that such adjustments shall not be deemed
to be included in Schedule 5.11 unless specifically listed thereon;
-32-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
7.3.10 commit a material breach or amend or terminate any
material agreement, permit, license or other right of the Company; or
7.3.11 enter into any other transaction outside the ordinary
course of its business or prohibited hereunder.
7.4 No Shop. The U.K. Stockholder shall not, and he shall not permit the
U.K. Company, nor any agent, officer, director, trustee or any representative of
any of the foregoing, during the period commencing on the date of this Agreement
and ending with the earlier to occur of the Closing Date or the termination of
this Agreement in accordance with its terms, directly or indirectly, to:
7.4.1 solicit or initiate the submission of proposals or offers
from any person for,
7.4.2 participate in any discussions pertaining to, or
7.4.3 furnish any information to any person other than
Healthworld or its authorized agents relating to, any acquisition or
purchase of all or a material amount of the assets of, or any equity
interest in, the Company, or a consolidation or business combination of
the Company.
7.5 Further Assurances. The parties hereto agree to execute and deliver, or
cause to be executed and delivered, such further instruments or documents or
take such other action as may be reasonably necessary or convenient to carry out
the transactions contemplated hereby.
7.6 Agreements. The U.K. Stockholder shall and he shall use commercially
reasonable efforts to cause the Company to terminate any stockholders
agreements, voting agreements, voting trusts, options, warrants and employment
agreements between the Company and any employee listed on Schedule 9.9 hereto on
or prior to the Closing Date.
7.7 Notification of Certain Matters. The U.K. Stockholder shall give prompt
notice to Healthworld and the U.S. Stockholders of:
7.7.1 the occurrence or non-occurrence of any event the
occurrence or non-occurrence of which would be likely to cause any
representation or warranty of the U.K. Stockholder contained herein to
be untrue or inaccurate in any material respect at or prior to the
Closing; and
-33-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
7.7.2 any material failure of the U.K. Stockholder, the Company
or any of its Subsidiaries to comply with or satisfy any covenant,
condition or agreement to be complied with or satisfied by such person
hereunder.
The delivery of any notice pursuant to this Section 7.7 shall not be deemed to
7.7.3 modify the representations or warranties hereunder of the
party delivering such notice, which modification may only be made
pursuant to Section 7.8,
7.7.4 modify the conditions set forth in Sections 8 and 9, or
7.7.5 limit or otherwise affect the remedies available hereunder
to the party receiving such notice.
7.8 Amendment of Schedules. Each party hereto agrees that, with respect to
the representations and warranties of such party contained in this Agreement,
such party shall have the continuing obligation until 24 hours prior to the
anticipated effectiveness of the Registration Statement to supplement or amend
promptly the Schedules hereto with respect to any matter hereafter arising or
discovered which, if existing or known at the date of this Agreement, would have
been required to be set forth or described in the Schedules, provided however,
that supplements and amendments to Schedules 5.10, 5.11, 5.14 and 5.15 shall
only have to be delivered at the Closing Date, unless such Schedule is to be
amended to reflect an event occurring other than in the ordinary course of
business.
7.9 Cooperation in Preparation of Registration Statement. The U.K.
Stockholder shall furnish or cause to be furnished to Healthworld and the
Underwriters all of the information concerning the Company and the U.K.
Stockholder required for inclusion in, and will cooperate with Healthworld and
the Underwriters in the preparation of, the Registration Statement and the
prospectus included therein (including audited and unaudited financial
statements, prepared in accordance with generally accepted accounting
principles, in form suitable for inclusion in the Registration Statement). The
U.K. Stockholder agrees promptly to advise Healthworld if at any time during the
period in which a prospectus relating to the IPO is required to be delivered
under the 1933 Act, any information contained in the prospectus concerning the
Company or the U.K. Stockholder becomes incorrect or incomplete in any material
respect, and to provide the information needed to correct such inaccuracy. The
U.K. Stockholder represents and warrants that the Registration Statement will
not include an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances in which they were made, not misleading; provided,
however, that the U.K. Stockholder shall not have responsibility for any such
inclusions or omissions to the extent they relate to the U.S. Companies and do
not relate to the Company.
-34-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
8 Conditions Precedent to Obligations of the U.K. Stockholder.
The obligations of the U.K. Stockholder with respect to actions to be taken
on the Closing Date are subject to the satisfaction or waiver on or prior to the
Closing Date of all of the following conditions.
8.1 Representations and Warranties; Performance of Obligations by
Healthworld. All representations and warranties of Healthworld contained in this
Agreement shall, if qualified as to materiality, be true and correct in all
material respects, and if not so qualified, be true and correct, as of the
Closing Date as though such representations and warranties had been made as of
that time. All of the terms, covenants and conditions of Healthworld contained
in this Agreement shall have been duly complied with and performed in all
material respects. Certificates to the foregoing effect dated the Closing Date,
signed by Healthworld, shall have been delivered to the U.K. Stockholder.
8.2 Satisfaction. All actions, proceedings, instruments and documents
required to carry out this Agreement and any other agreement incidental hereto
and all other related legal matters shall be reasonably satisfactory to the U.K.
Stockholder and his counsel. The U.K. Stockholder shall be reasonably satisfied
that the Registration Statement and the prospectus forming a part thereof,
including any amendments thereof or supplements thereto, shall not contain any
untrue statement of a material fact, or omit to state therein a material fact
required to be stated therein or necessary to make the statements therein not
misleading, provided that the condition contained in this sentence shall be
deemed satisfied if the U.K. Stockholder shall have failed to inform Healthworld
in writing prior to the effectiveness of the Registration Statement of the
existence of an untrue statement of a material fact or the omission of such a
statement of a material fact.
8.3 No Litigation. No action or proceeding before a court or any other
governmental agency or body shall have been instituted or threatened to restrain
or prohibit the Organization or the IPO and no governmental agency or body shall
have taken any other action or made any request of the Company or the U.K.
Stockholder as a result of which the U.K. Stockholder deems it inadvisable to
proceed with the transactions hereunder.
8.4 Opinions of Counsel. The U.K. Stockholder shall have received an
opinion from counsel for each of the U.S. Stockholders, ▇▇▇▇▇▇ and Healthworld,
dated the Closing Date, in form and substance reasonably acceptable to counsel
for the U.K. Stockholder.
8.5 Consents and Approvals. All necessary consents of and filings with any
governmental authority or agency relating to the consummation of the transaction
contemplated herein shall have been obtained and made.
-35-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
8.6 No Material Adverse Change. No event or circumstance shall have
occurred with respect to any of the U.S. Companies which would constitute a
Material Adverse Effect.
8.7 Secretary's Certificates; Good Standing. The U.K. Stockholder shall
have received (a) certificates, dated the Closing Date and signed by the
secretary of the U.S. Companies certifying the truth and correctness of attached
copies of the U.S. Companies' respective Certificates of Incorporation
(including amendments thereto) and By-Laws (including amendments thereto) and
such other matters as may reasonably be requested by the U.K. Stockholder, (b) a
certificate, dated the Closing Date and signed by the secretary of Healthworld,
certifying the truth and correctness of attached copies of Healthworld's
certificate of incorporation (including amendments thereto) and by-laws
(including amendments thereto) and such other matters as may reasonably be
requested by the U.K. Stockholder, and (c) a certificate of good standing for
Healthworld in the State of Delaware.
8.8 Simultaneous Closings. The Closings pursuant to the Sister Company
Agreements of Organization, the U.K. Agreement of Organization and the U.S.
Agreement of Organization shall have occurred simultaneously with the Closing
hereunder.
9 Conditions Precedent to Obligations of Healthworld.
The obligations of Healthworld with respect to actions to be taken on the
Closing Date are subject to the satisfaction or waiver on or prior to the
Closing Date of all of the following conditions.
9.1 Representations and Warranties; Performance of Obligations. All the
representations and warranties of the U.K. Stockholder contained in this
Agreement shall, if qualified as to materiality, be true and correct in all
material respects, and if not so qualified, be true and correct, as of the
Closing Date with the same effect as though such representations and warranties
had been made on and as of such date; all of the terms, covenants and conditions
of this Agreement to be complied with or performed by the U.K. Stockholder and
the U.K. Company on or before the Closing Date shall have been duly performed or
complied with in all material respects; and the U.K. Stockholder shall have
delivered to Healthworld certificates dated the Closing Date and signed by him
to such effect.
9.2 Satisfaction. All actions, proceedings, instruments and documents
required to carry out this Agreement and the respective Organization Agreements
of the U.S. Stockholders and the Contributing Minority Stockholders and any
other agreement incidental hereto or thereto and all other related legal matters
shall be reasonably satisfactory to Healthworld and its counsel. Healthworld
shall be satisfied that the Registration Statement and the prospectus forming a
part thereof, including any amendments thereof or supplements thereto,
-36-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
shall not contain any untrue statement of a material fact, or omit to state
therein a material fact required to be stated therein or necessary to make the
statements therein not misleading.
9.3 No Litigation. No action or proceeding before a court or any other
governmental agency or body shall have been instituted or threatened to restrain
or prohibit the Organization or the IPO and no governmental agency or body shall
have taken any other action or made any request of Healthworld or any Company as
a result of which the management of Healthworld deems it inadvisable to proceed
with the transactions hereunder.
9.4 Opinion of Counsel. Healthworld shall have received an opinion from
counsel to the U.K. Stockholder, dated the Closing Date, in form and substance
reasonably acceptable to counsel for Healthworld.
9.5 Consents and Approvals. All necessary consents of and filings with any
governmental authority or agency relating to the consummation of the transaction
contemplated herein shall have been obtained and made.
9.6 No Material Adverse Change. No event or circumstance shall have
occurred with respect to the Company which would constitute a Material Adverse
Effect, and the Company shall not have suffered any material loss or damages to
any of its properties or assets, whether or not covered by insurance, which
change, loss or damage materially affects or impairs the ability of the Company
to conduct its businesses.
9.7 Secretary's Certificates. Healthworld shall have received certificates,
dated the Closing Date and signed by the secretary of the Company, certifying
the truth and correctness of attached copies of the Company's Certificate of
Incorporation (including amendments thereto), and Memorandum and Articles of
Association (including amendments thereto).
9.8 Stockholder's Release. The U.K. Stockholder shall have delivered to
Healthworld an instrument dated the Closing Date releasing the Company from any
and all claims of the U.K. Stockholder against the Company and Healthworld and
obligations of the Company and Healthworld to the U.K. Stockholder, except for
(x) items specifically identified on Schedules 5.10 and 5.15 as being claims of
or obligations to the U.K. Stockholder, (y) continuing obligations to the U.K.
Stockholder relating to his employment by Healthworld and (z) obligations
arising under this Agreement or the transactions contemplated hereby.
9.9 Termination of Related Party Agreements. Except as set forth on
Schedule , all existing agreements between any of the Company, the U.K.
Stockholder, Milton, Garnham, Moreton and Cater shall have been canceled
effective as of the Closing Date.
-37-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
9.10 Simultaneous Closings. The Closings pursuant to the Organization
Agreements with respect to the U.S. Stockholders, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇ and Moreton
shall occur simultaneously with the Closing hereunder.
9.11 Cater Share Purchase. The U.K. Company shall have purchased Cater's
shares as described in Section 1.1.3.
10 Covenants of Healthworld and the U.K. Stockholder after Closing.
10.1 Release From Guarantees; Repayment of Certain Obligations. Healthworld
shall use commercially reasonable efforts to have the U.K. Stockholder released
from any and all guarantees on any indebtedness or obligation that he personally
guaranteed and from any and all pledges of assets that he pledged to secure such
indebtedness or obligation for the benefit of the Company, with all such
guarantees on indebtedness or obligation being assumed by Healthworld. In the
event that Healthworld cannot obtain such releases from the lenders of any such
guaranteed indebtedness or the obligee of any guaranteed obligation on or prior
to 120 days subsequent to the Closing Date, Healthworld shall pay off or
otherwise refinance or retire such indebtedness or obligation. From and after
the Closing Date and until such time as all of such indebtedness or obligation
is paid off, refinanced or retired, Healthworld shall maintain unencumbered
funds in amounts sufficient to provide for such pay off, refinancing or
retirement, provided that Healthworld may use such funds for other purposes, in
its sole discretion, with the prior written consent of the U.K. Stockholder.
Furthermore, Healthworld shall assume all obligations which the U.K. Stockholder
may have incurred to guarantee any lease of the Company and shall indemnify and
hold harmless the U.K. Stockholder from any cost or expense arising under any
such lease guarantee.
10.2 Preservation of Tax and Accounting Treatment. Except as contemplated
by this Agreement or the Registration Statement, after the Closing Date,
Healthworld shall not and shall not permit any of its Subsidiaries to undertake
any act that would jeopardize the tax-free status of the Organization.
10.3 Preparation and Filing of Tax Returns.
10.3.1 The Company shall file or cause to be filed all required
separate Returns of any Acquired Party for all taxable periods that end
on or before the Closing Date in a manner prepared under the
instructions of ▇▇▇▇▇▇, consistent with historical practices.
10.3.2 Healthworld shall file or cause to be filed all required
separate Returns of, or that include, any Acquired Party for all taxable
periods ending after the Closing Date.
-38-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
10.3.3 Each party hereto shall, and shall cause its Subsidiaries
and Affiliates to, provide to each of the other parties hereto such
cooperation and information as any of them reasonably may request in
filing any Return, amended Return or claim for refund, determining a
liability for Taxes or a right to refund of Taxes or in conducting any
audit or other proceedings in respect of Taxes. Such cooperation and
information shall include providing copies of all relevant portions of
relevant Returns, together with relevant accompanying schedules and
relevant work papers, relevant documents relating to rulings or other
determinations by taxing authorities and relevant records concerning
the ownership and tax basis of property, which such party may possess.
Each party shall make its employees reasonably available on a mutually
convenient basis at its cost to provide explanation of any documents
or information so provided. Subject to the preceding sentence, each
party required to file Returns pursuant to this Agreement shall bear
all costs of filing such Returns.
10.3.4 Healthworld and the U.K. Stockholder shall comply with,
and the U.K. Stockholder shall use commercially reasonable efforts to
cause the Company to comply with, the Tax reporting requirements of
Section 1.351-3 of the Treasury Regulations promulgated under the
Code, and treat the transaction as a tax-free contribution under
Section 351(a) of the Code.
10.4 Conformity With ▇▇▇▇▇▇▇▇/▇▇▇▇▇▇ Letter of Intent Regarding Governance.
Corporate governance at the date of the closing of the IPO shall be in
accordance with section 1.3 of the ▇▇▇▇▇▇▇▇/▇▇▇▇▇▇ Letter of Intent.
11 Indemnification.
The U.K. Stockholder and Healthworld each make the following covenants that
are applicable to them, respectively:
11.1 General Indemnification by the U.K. Stockholder. The U.K. Stockholder
covenants and agrees he will indemnify, defend, protect and hold harmless
Healthworld at all times, from and after the date of this Agreement until the
Expiration Date, from and against all claims, damages, actions, suits,
proceedings, demands, assessments, adjustments, costs and expenses (including
specifically, but without limitation, reasonable attorneys' fees and expenses of
investigation) incurred by Healthworld as a result of or arising from:
11.1.1 any breach of the representations or warranties of the U.K.
Stockholder set forth herein or on the Disclosure Schedules or certificates
delivered by him in connection herewith,
11.1.2 any breach of any covenant or agreement on the part of the U.K.
Stockholder under this Agreement, or
-39-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
11.1.3 any liability under the 1933 Act, the 1934 Act or other
Federal or state law or regulation, at common law or otherwise,
arising out of or based upon any untrue written statement or alleged
untrue written statement of a material fact relating to any the
Company or the U.K. Stockholder, and provided to Healthworld or its
counsel by the U.K. Stockholder in the Registration Statement or any
prospectus forming a part thereof, or any amendment thereof or
supplement thereto, or arising out of or based upon any omission or
alleged omission to state therein a material fact relating to the
Company or the U.K. Stockholder required to be stated therein or
necessary to make the statements therein not misleading.
11.2 Indemnification by Healthworld. Healthworld covenants and agrees that
it will indemnify, defend, protect and hold harmless the U.K. Stockholder at all
times from and after the date of this Agreement until the Expiration Date, from
and against all claims, damages, actions, suits, proceedings, demands,
assessments, adjustments, costs and expenses (including specifically, but
without limitation, reasonable attorneys, fees and expenses of investigation)
incurred by the U.K. Stockholder as a result of or arising from:
11.2.1 any breach by Healthworld of its representations and
warranties set forth herein or on the Disclosure Schedules or
certificates delivered by it in connection herewith;
11.2.2 any breach of any covenant or agreement on the part of
Healthworld under this Agreement,
11.2.3 any liability under the 1933 Act, the 1934 Act or other
Federal or state law or regulation, at common law or otherwise,
arising out of or based upon any untrue statement or alleged untrue
statement of a material fact relating to Healthworld or any of the
other company forming a part of the Healthworld Plan of Organization
contained in any preliminary prospectus, the Registration Statement or
any prospectus forming a part thereof, or any amendment thereof or
supplement thereto, or arising out of or based upon any omission or
alleged omission to state therein a material fact relating to
Healthworld or any other company forming a part of the Healthworld
Plan of Organization required to be stated therein or necessary to
make the statements therein not misleading, or
11.2.4 any representation or warranty relating to Healthworld's
right, authority or capacity to enter into and consummate the terms of
this Agreement.
11.3 Third Person Claims. Promptly after any party hereto (hereinafter the
"Indemnified Party") has received notice of or has knowledge of any claim by a
person not a party to this Agreement ("Third Person"), or the commencement of
any action or proceeding by a Third Person, the Indemnified Party shall, as a
condition precedent to a claim with respect thereto being made against any party
obligated to provide indemnification pursuant to Section 11.1 or 11.2 hereof
(hereinafter the "Indemnifying Party"), give the Indemnifying Party written
-40-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
notice of such claim or the commencement of such action or proceeding. Such
notice shall state the nature and the basis of such claim and a
reasonableestimate of the amount thereof. The Indemnifying Party shall have the
right to defend and settle, at its own expense and by its own counsel, any such
matter so long as the Indemnifying Party pursues the same in good faith and
diligently, provided that the Indemnifying Party shall not settle any criminal
proceeding or any other proceeding to the extent that relief other than the
payment of money is sought, without the written consent of the Indemnified
Party. If the Indemnifying Party undertakes to defend or settle, it shall
promptly notify the Indemnified Party of its intention to do so, and the
Indemnified Party shall cooperate with the Indemnifying Party and its counsel in
the defense thereof and in any settlement thereof. Such cooperation shall
include, but shall not be limited to, furnishing the Indemnifying Party with any
books, records or information reasonably requested by the Indemnifying Party
that are in the Indemnified Party's possession or control. All Indemnified
Parties shall use the same counsel, which shall be the counsel selected by
Indemnifying Party, provided that if counsel to the Indemnifying Party shall
have a conflict of interest that prevents counsel for the Indemnifying Party
from representing Indemnified Party, Indemnified Party shall have the right to
participate in such matter through counsel of its own choosing and Indemnifying
Party shall reimburse the Indemnified Party for the reasonable expenses of its
counsel. After the Indemnifying Party has notified the Indemnified Party of its
intention to undertake to defend or settle any such asserted liability, and for
so long as the Indemnifying Party diligently pursues such defense, the
Indemnifying Party shall not be liable for any additional legal expenses
incurred by the Indemnified Party in connection with any defense or settlement
of such asserted liability, except as set forth in the preceding sentence and to
the extent such participation is requested by the Indemnifying Party, in which
event the Indemnified Party shall be reimbursed by the Indemnifying Party for
reasonable additional legal expenses and out-of-pocket expenses. If the
Indemnifying Party desires to accept a final and complete settlement of any such
Third Person claim and the Indemnified Party refuses to consent to such
settlement, then the Indemnifying Party's liability under this Section with
respect to such Third Person claim shall be limited to the amount so offered in
settlement by said Third Person. Upon agreement as to such settlement between
said Third Person and the Indemnifying Party, the Indemnifying Party shall, in
exchange for a complete release from the Indemnified Party, promptly pay to the
Indemnified Party the amount agreed to in such settlement and the Indemnified
Party shall, from that moment on, bear full responsibility for any additional
costs of defense which it subsequently incurs with respect to such claim and all
additional costs of settlement or judgment. If the Indemnifying Party does not
undertake to defend such matter to which the Indemnified Party is entitled to
indemnification hereunder, or fails diligently to pursue such defense, the
Indemnified Party may undertake such defense through counsel of its choice, at
the cost and expense of the Indemnifying Party, and the Indemnified Party may
settle such matter, and the Indemnifying Party shall reimburse the Indemnified
Party for the amount paid in such settlement and any other liabilities or
expenses incurred by the Indemnified Party in connection therewith, provided,
however, that under no circumstances shall the Indemnified Party settle any
Third Person claim without the written consent of the Indemnifying Party, which
-41-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
consent shall not be unreasonably withheld or delayed. All settlements hereunder
shall effect a complete release of the Indemnified Party, unless the Indemnified
Party otherwise agrees in writing. The parties hereto will make appropriate
adjustments for insurance proceeds in determining the amount of any
indemnification obligation under this Section.
11.4 Exclusive Remedy. The indemnification provided for in this Section 11
shall be the exclusive remedy in any action seeking damages or any other form of
monetary relief brought by any party to this Agreement against another party,
provided that, nothing herein shall be construed to limit the right of a party,
in a proper case, to seek injunctive relief for a breach of this Agreement.
11.5 Limitations on Indemnification.
11.5.1 Healthworld shall not assert any claim for indemnification
hereunder against the U.K. Stockholder until such time as, and solely
to the extent that, the aggregate of all claims which Healthworld may
have against the U.K. Stockholder shall exceed (pound)31,250,
provided, however, that Healthworld may assert and shall be
indemnified for any claim under any Absolute Representation at any
time, regardless of whether the aggregate of all claims which such
persons may have against the U.K. Stockholder exceeds (pound)31,250,
it being understood that the amount of any such claim under any
Absolute Representation shall not be counted towards such
(pound)31,250 amount.
11.5.2 The U.K. Stockholder shall not assert any claim for
indemnification hereunder against Healthworld until such time as, and
solely to the extent that, the aggregate of all claims which the U.K.
Stockholder may have against Healthworld shall exceed (pound)31,250,
provided, however that the U.K. Stockholder may assert and shall be
indemnified for any claim under Section 11.2.4 at any time, regardless
of whether the aggregate of all claims which the U.K. Stockholder may
have against Healthworld exceeds (pound)31,250, it being understood
that the amount of any such claim under Section 11.2.4 shall not be
counted towards such (pound)31,250 amount.
11.5.3 No person shall be entitled to indemnification under this
Section 11 if and to the extent that such person's claim for
indemnification is directly or indirectly related to a breach by such
person of any representation, warranty, covenant or other agreement
set forth in this Agreement. Notwithstanding any other term of this
Agreement (except the proviso to this sentence), the U.K. Stockholder
shall not be liable under this Section 11 for an amount which exceeds
the value of the Healthworld Stock to be received by the U.K.
Stockholder in connection with the Organization, provided that the
U.K. Stockholder's indemnification obligations pursuant to any
Absolute Representation shall not be limited. For purposes of
calculating the value of the Healthworld Stock to be received by the
U.K. Stockholder, Healthworld Stock shall be valued at its initial
public offering price as set forth in the
-42-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
Registration Statement. It is hereby understood and agreed that the U.K.
Stockholder may satisfy an indemnification obligation through payment of
Healthworld Stock, such satisfaction to be to the extent of the then fair market
value of Healthworld Stock conveyed by the Indemnifying Party pursuant to such
indemnification.
12 Termination of Agreement.
12.1 Termination. This Agreement may be terminated at anytime prior to the
Closing Date solely:
12.1.1 by request of the U.K. Stockholder, with the consent of
Healthworld, ▇▇▇▇▇▇ and the U.S. Stockholders;
12.1.2 by the U.K. Stockholder or Healthworld if the transactions
contemplated by this Agreement to take place at the Closing shall not
have been consummated by December 31, 1997, unless the failure of such
transactions to be consummated is due to the willful failure of the
party invoking this subsection to perform any of his or its
obligations under this Agreement to the extent required to be
performed by him or it prior to or on the Closing Date;
121.1.3 by the U.K. Stockholder, on the one hand, or by
Healthworld, on the other hand, if a material breach or default shall
be made by the other party in the observance or in the due and timely
performance of any of the covenants, agreements or conditions
contained herein, and the curing of such default shall not have been
made on or before the Closing Date; or
12.1.4 by Healthworld, if a material breach or default shall be
made by any U.S. Stockholder or ▇▇▇▇▇▇ in the observance or in the due
and timely performance of any of the covenants, agreements or
conditions contained in their respective agreements, and the curing of
such default shall not have been made on or before the Closing Date.
12.2 Liabilities in Event of Termination.
The termination of this Agreement will in no way limit any obligation or
liability of any party based on or arising from a breach or default by such
party with respect to any of its representations, warranties, covenants or
agreements contained in this Agreement including, but not limited to, legal and
audit costs and out of pocket expenses.
13 Non-Competition; Non-Disclosure.
13.1 Non-Competition. The U.K. Stockholder will not, for a period (the
"Restrictive Period") commencing with the date hereof and ending six (6) months
following the later of (i) the Closing Date or (ii) the termination of the U.K.
Stockholder's employment with
-43-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
the Company, for any reason whatsoever, directly or indirectly, for himself or
on behalf of or in conjunction with any other person, persons, company,
partnership, corporation or business of whatever nature:
13.1.1 as an officer, director, shareholder, owner, partner,
joint venturer, or in a managerial capacity, whether as an employee,
independent contractor, consultant or advisor, or as a sales
representative (except that the U.K. Stockholder may be employed by an
entity engaged in the advertising business so long as the U.K.
Stockholder does not have contact with or provide services to or for the
benefit of any such client) within the "Territory" (hereafter defined):
13.1.1.1 engage in any advertising business having as a
client any corporation or any other entity which was a client of
Healthworld or any of its Subsidiaries at any time during the
two (2) year period (the "Contact Period") ending with the last
day of the Restrictive Period; or
13.1.1.2 engage in any mass media communication of
health-related information, whether by means of publishing,
television, radio, the internet or otherwise; or
13.1.1.3 engage in any other business engaged in by
Healthworld or any of its subsidiaries at any time during the
Contact Period.
The term "Territory" means each of the geographic areas which lie within a 75
mile radius of any location at which Healthworld or any of its subsidiaries
(which were subsidiaries of Healthworld at any time during the Contact Period)
conducted any business during the Restrictive Period.
13.1.2 call upon any person who is, at that time, an employee of
Healthworld (including the subsidiaries thereof) in a sales
representative or managerial capacity for the purpose or with the intent
of enticing such employee away from or out of the employ of Healthworld
(including the subsidiaries thereof), provided that the U.K. Stockholder
shall be permitted to call upon and hire any member of his or her
immediate family;
13.1.3 call upon any person or entity which is, at that time, or
which has been, at any time within the Contact Period, a customer of
Healthworld (including the subsidiaries thereof) for the purpose of
soliciting or selling products or services in direct competition with
Healthworld within the Territory;
-44-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
13.1.4 call upon any prospective acquisition candidate, on the
U.K. Stockholder's own behalf or on behalf of any competitor in the
advertising business or in the business of communicating health
information through mass media, which candidate, to the actual knowledge
of the U.K. Stockholder after due inquiry, was called upon by
Healthworld (including the subsidiaries thereof) at any time during the
Contact Period or for which, to the actual knowledge of the U.K.
Stockholder after due inquiry, Healthworld (or any subsidiary thereof)
at any time during the Contact Period made an acquisition analysis, for
the purpose of acquiring such entity; or
13.1.5 disclose customers, whether in existence or proposed, of
Healthworld (or any subsidiary thereof) to any person, firm,
partnership, corporation or business for any reason or purpose
whatsoever, except to the extent that Healthworld (or any subsidiary
thereof) has in the past disclosed such information to the public for
valid business reasons.
Notwithstanding the above, the foregoing covenant shall not be deemed to
prohibit the U.K. Stockholder from acquiring as an investment not more than one
percent (1%) of the capital stock of a competing business whose stock is traded
on a national securities exchange or over-the-counter.
13.2 Nondisclosure.
13.2.1 Definitions. The U.K. Stockholder recognizes and
acknowledges that he has had in the past, currently has, and in the
future may possibly have, access to certain confidential information of
Healthworld or any of its Subsidiaries, such as operational policies,
and pricing and cost policies that are valuable, special and unique
assets of Healthworld and its Subsidiaries, and/or their respective
businesses (the "Confidential Information"). Confidential Information
shall not include any information:
13.2.1.1 which becomes known to the public generally through
no fault of the U.K. Stockholder,
13.2.1.2 as to which disclosure is required by law or the
order of any governmental authority under color of law;
provided, that prior to disclosing any information
pursuant to this clause 13.2.1.2, the U.K. Stockholder
shall give prior written notice thereof to Healthworld
and provide Healthworld with the opportunity to contest
such disclosure, or
-45-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
13.2.1.3 as to which the disclosing party reasonably
believes that such disclosure is required in connection
with the defense of a lawsuit against the disclosing
party.
13.2.2 Covenant to Maintain Confidentiality. The U.K. Stockholder
agrees that until the later to occur of (i) five (5) years following
the Closing Date or (ii) with respect to any portion of the
Confidential Information the date upon which such portion no longer
meets the definition of "Confidential Information", he will not
disclose Confidential Information to any person, firm, corporation,
association or other entity for any purpose or reason whatsoever,
except
13.2.2.1 to authorized representatives of Healthworld,
13.2.2.2 during the course of the U.K. Stockholder's
employment by Healthworld or any of its Subsidiaries, such
information may be disclosed by the U.K. Stockholder as is
required in the course of performing his duties and
13.2.2.3 to counsel and other advisers, provided that
such advisers (other than counsel) agree to the confidentiality
provisions of this Section 13.2.
13.3 Injunctive Relief; Damages. Because of the difficulty of measuring
economic losses to Healthworld as a result of a breach of the foregoing
covenants in this Section , and because of the immediate and irreparable damage
that could be caused to Healthworld for which it would have no other adequate
remedy, the U.K. Stockholder agrees that the foregoing covenants may be enforced
by Healthworld in the event of breach by the U.K. Stockholder, by injunctions
and restraining orders. Nothing herein shall be construed as prohibiting
Healthworld from pursuing any other available remedy for such breach or
threatened breach, including the recovery of damages.
13.4 Reasonable Restraint. It is agreed by the parties hereto that the
foregoing covenants in this Section 13 impose a reasonable restraint on the U.K.
Stockholder in light of the activities and business of Healthworld (including
the Subsidiaries thereof) on the date of the execution of this Agreement and the
current plans of Healthworld contained in the Registration Statement.
13.5 Severability; Reformation. The covenants in this Section are severable
and separate, and the unenforceability of any specific covenant shall not affect
the provisions of any other covenant. Moreover, in the event any court of
competent jurisdiction shall determine that the scope, time or territorial
restrictions set forth are unreasonable, then it is the intention of
-46-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
the parties that such restrictions be enforced to the fullest extent which the
court deems reasonable, and the Agreement shall thereby be reformed.
13.6 Independent Covenant. All of the covenants in this Section 13 shall be
construed as an agreement independent of any other provision in this Agreement,
and the existence of any claim or cause of action by the U.K. Stockholder
against Healthworld (including the subsidiaries thereof), whether predicated on
this Agreement or otherwise, shall not constitute a defense to the enforcement
by Healthworld of such covenants. It is specifically agreed that the Restrictive
Period stated at the beginning of Section 13.1, during which the agreements and
covenants of the U.K. Stockholder made in Section 13.1 shall be effective, shall
be computed by extending the Restrictive Period by the amount of time during
which the U.K. Stockholder is in violation of any provision of Section 13.1. The
covenants contained in this Section shall not be affected by any breach of any
other provision hereof by any party hereto.
13.7 Survival. The obligations of the parties under this Section shall
survive the termination of this Agreement.
14 Federal Securities Act Representations.
The U.K. Stockholder acknowledges that the shares of Healthworld Stock to
be delivered to him pursuant to this Agreement have not been and will not be
registered under the 1933 Act and therefore may not be resold without compliance
with the 1933 Act. The Healthworld Stock to be acquired by the U.K. Stockholder
pursuant to this Agreement is being acquired solely for his own account, for
investment purposes only, and with no present intention of distributing, selling
or otherwise disposing of it in connection with a distribution.
14.1 Compliance with Law. The U.K. Stockholder covenants, warrants and
represents that none of the shares of Healthworld Stock issued to him will be
offered, sold, assigned, pledged, hypothecated, transferred or otherwise
disposed of except after full compliance with all of the applicable provisions
of the Act and the rules and regulations of the SEC. All the Healthworld Stock
issued pursuant to the transactions contemplated hereby shall bear the following
legend: THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933 (THE "ACT") AND MAY ONLY BE SOLD OR OTHERWISE TRANSFERRED
IF THE HOLDER HEREOF COMPLIES WITH THE ACT AND APPLICABLE SECURITIES LAW.
14.2 Economic Risk; Sophistication. The U.K. Stockholder is able to bear
the economic risk of an investment in the Healthworld Stock acquired pursuant to
this Agreement and can afford to sustain a total loss of such investment and has
such knowledge and experience in financial and business matters that he is
capable of evaluating the merits and risks of the proposed investment in the
Healthworld Stock. The U.K. Stockholder has had an adequate
-47-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
opportunity to ask questions and receive answers from the officers of
Healthworld concerning any and all matters relating to the transactions
described herein including, without limitation, the background and experience of
the current and proposed officers and directors of Healthworld, the plans for
the operations of the business of Healthworld, the business, operations and
financial condition of the companies which are entering into the Organization
but are not owned by the U.K. Stockholder, and any plans for additional
acquisitions and the like. The U.K. Stockholder has asked any and all questions
in the nature described in the preceding sentence and all questions have been
answered to his satisfaction.
15 Registration Rights.
15.1 Piggyback Registration Rights. At any time commencing one (1) year
following the Closing, whenever Healthworld proposes to register any Healthworld
Stock for its own or others account under the 1933 Act for a public offering
(other than a registration statement on Form ▇-▇, ▇▇▇▇ ▇-▇, or any successor
form), Healthworld shall give the U.K. Stockholder prompt written notice of its
intent to do so. Upon the written request of the U.K. Stockholder given within
30 days after receipt of such notice, Healthworld shall cause to be included in
such registration all of the Healthworld Stock issued to the U.K. Stockholder
pursuant to this Agreement (including any stock issued as (or issuable upon the
conversion or exchange of any convertible security, warrant, right or other
security which is issued by Healthworld as) a dividend or other distribution
with respect to, or in exchange for, or in replacement of such Healthworld
Stock) which the U.K. Stockholder requests, provided that Healthworld shall have
the right to reduce the number of shares included in such registration to the
extent that inclusion of such shares could, in the opinion of tax counsel to
Healthworld or its independent auditors, jeopardize the status of the
transactions contemplated hereby and by the Registration Statement as a tax-free
organization or jeopardize the ability of Healthworld to utilize
pooling-of-interest accounting. In addition, Healthworld shall have the right to
reduce the number of shares included in such registration if and to the extent
Healthworld is advised by the underwriters of an underwritten offering of the
securities being offered pursuant to any registration statement under this
Section 15.1 that the number of shares to be sold by persons other than
Healthworld is greater than the number of such shares which can be offered
without adversely affecting the offering. Any such reduction shall be made pro
rata based on the number of shares offered for the accounts of such persons
(based upon the number of shares held by such person).
15.2 Registration Procedures. All expenses incurred in connection with the
registrations under this Article 15 (including all registration, filing,
qualification, legal, printer and accounting fees, but excluding underwriting
commissions and discounts), shall be borne by Healthworld. In connection with
registrations under Section 15.1, Healthworld shall use commercially reasonable
efforts to prepare and file with the SEC as soon as reasonably practicable, a
registration statement with respect to the Healthworld Stock and use its best
efforts
-48-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
to cause such registration to promptly become and remain effective for a period
of at least 90 days (or such shorter period during which holders shall have sold
all Healthworld Stock which they requested to be registered); use its best
efforts to register and qualify the Healthworld Stock covered by such
registration statement under applicable state securities laws as the holders
shall reasonably request for the distribution for the Healthworld Stock; and
take such other actions as are reasonable and necessary to comply with the
requirements of the 1933 Act and the regulations thereunder.
15.3 Underwriting Agreement. In connection with each registration pursuant
to Section 15.1 covering an underwritten registration public offering,
Healthworld and each participating holder agree to enter into a written
agreement with the underwriters in such form and containing such provisions as
are customary in the securities business for such an arrangement between the
underwriters and companies of Healthworld's size and investment stature,
including indemnification.
15.4 Availability of Rule 144. Healthworld shall not be obligated to
register shares of Healthworld Stock held by the U.K. Stockholder at any time
when the resale provisions of Rule 144(k) (or any similar or successor
provision) promulgated under the 1933 Act are available to the U.K. Stockholder.
16 General.
16.1 Cooperation. The U.K. Stockholder and Healthworld shall each deliver
or cause to be delivered, and the U.K. Stockholder shall use commercially
reasonable efforts to cause the Company to deliver, to the other on the Closing
Date, and at such other times and places as shall be reasonably agreed to, such
additional instruments as the other may reasonably request for the purpose of
carrying out this Agreement . The U.K. Stockholder shall use commercially
reasonable efforts to cause the Company to cooperate and use its reasonable
efforts to have their respective present officers, directors and employees
cooperate with Healthworld on and after the Closing Date in furnishing
information, evidence, testimony and other assistance in connection with any
Return filing obligations, actions, proceedings, arrangements or disputes of any
nature with respect to matters pertaining to all periods prior to the Closing
Date.
16.2 Successors and Assigns. This Agreement and the rights of the parties
hereunder may not be assigned (except by operation of law) and shall be binding
upon and shall inure to the benefit of the parties hereto, the successors of
Healthworld, and the heirs and legal representatives of the U.K. Stockholder.
16.3 Entire Agreement. Except as otherwise provided herein, this Agreement
(including the schedules, exhibits and annexes attached hereto) and the
documents
-49-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
delivered pursuant hereto constitute the entire agreement and understanding
among the U.K. Stockholder and Healthworld and supersede any prior agreement and
understanding relating to the subject matter of this Agreement. This Agreement,
upon execution, constitutes a valid and binding agreement of the parties hereto
enforceable in accordance with its terms and may be modified or amended only by
a written instrument executed by the U.K. Stockholder and Healthworld (acting
through its officers, duly authorized by its Board of Directors).
16.4 Counterparts. This Agreement may be executed simultaneously in two (2)
or more counterparts, each of which shall be deemed an original and all of which
together shall constitute but one and the same-instrument.
16.5 Expenses. If the transactions herein contemplated shall be
consummated, Healthworld will pay the fees, expenses and disbursements of
Healthworld and its agents, representatives, accountants and counsel incurred in
connection with the preparation and filing of the registration statement, the
underwriting and the IPO, including all costs and expenses incurred in the
performance and compliance with all conditions to be performed by Healthworld
under this Agreement, including the fees and expenses of ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, LLP,
▇▇▇▇▇▇▇▇ & ▇▇▇▇▇ LLP, Todtman, Nachamie, ▇▇▇▇▇▇▇ & Spizz, P.C. (as they relate
to the subject matter described in this paragraph), the Underwriters or any
other person or entity retained by Healthworld (the "IPO costs").
If the transactions herein contemplated shall not be consummated, then the IPO
costs shall be paid 69% by the U.S. Companies and 31% by the U.K. Company. The
U.S. Companies and the U.K. Company shall contribute to (and, if necessary,
reimburse each other for) any such required payments in such proportions.
Notwithstanding the foregoing, in the event any indemnity obligation arises to
the Underwriters pursuant to any agreement between the Underwriters and
Healthworld, the U.K. Stockholder, the U.S. Stockholders, the U.K. Company
and/or the U.S. Companies with respect to the Underwriters' services in
contemplation of the IPO, then the breaching party shall be solely responsible
for such indemnification obligations and the non-breaching party shall be
entitled to reimbursement from the breaching party for any payment made by the
non-breaching party in respect thereof.
If the transactions herein contemplated shall be consummated, Healthworld shall
pay the fees, expenses and disbursements of Healthworld and the U.K. Stockholder
and his agents, representatives, accountants and counsel incurred in connection
with the negotiation and consummation of this Agreement and any amendments
thereto, including all counsel and professional costs of the U.K. Stockholder
relating to the negotiation and consummation of this Agreement (the
"Reorganization Costs"), but not including the cost of any broker or agent
described in Section 5.26.
-50-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
If the transactions herein contemplated shall not be consummated, the U.K.
Stockholder shall pay his Reorganization Costs.
Any other costs and expenses of the U.K. Stockholder which are not described as
IPO Costs or Reorganization Costs shall be paid by the U.K. Stockholder,
including but not limited to the cost of any broker or agent described in
Section 5.26, except that Healthworld shall pay all stock transfer and/or
recording taxes or duties imposed with respect to stock transfers effectuated
pursuant to the Organization. The U.K. Stockholder acknowledges that he, and not
Healthworld, will pay all Taxes due upon receipt of the consideration payable
pursuant to Section 2 hereof, and will assume all Tax risks and liabilities of
the U.K. Stockholder in connection with the transactions contemplated hereby,
except as otherwise specifically contemplated in this Section 16.5.
16.6 Notices. All notices of communication required or permitted hereunder
shall be in writing and may be given by depositing the same in United States
mail, addressed to the party to be notified, postage prepaid and registered or
certified with return receipt requested, or by delivering the same in person to
an officer or agent of such party.
16.6.1 If to Healthworld,
▇▇▇ ▇▇▇▇▇▇ ▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇
Attn: Chairman of the Board and
Chief Executive Officer
With copies to:
Rosenman & Colin LLP Todtman, Nachamie,
▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & Spizz, P.C.
▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇.
Attn: ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇
Attn: ▇▇▇▇ ▇▇▇▇▇
16.6.2 If to the U.K. Stockholder, addressed to him at his
address first set forth th copies to
▇▇▇▇ & Priest, LLP Rakisons
▇▇ ▇. ▇▇▇▇ ▇▇. ▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ INF
Attn: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ Attn: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
-51-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
or to such other address or counsel as any party hereto shall specify pursuant
to this Section from time to time.
16.7 Governing Law. This Agreement shall be construed in accordance with
the laws of the State of New York, without giving effect to any requirements
thereof which might otherwise cause the application of the law of another
jurisdiction, and the parties consent to New York as the exclusive venue for
resolving any and all disputes that may arise concerning this Agreement.
16.8 Exercise of Rights and Remedies. Except as otherwise provided herein,
no delay of or omission in the exercise of any right, power or remedy accruing
to any party as a result of any breach or default by any other party under this
Agreement shall impair any such right, power or remedy, nor shall it be
construed as a waiver of or acquiescence in any such breach or default, or of
any similar breach or default occurring later; nor shall any waiver of any
single breach or default be deemed a waiver of any other breach or default
occurring before or after that waiver.
16.9 Time. Time is of the essence with respect to this Agreement.
16.10 Reformation and Severability. In case any provision of this Agreement
shall be invalid, illegal or unenforceable, it shall, to the extent possible, be
modified in such manner as to be valid, legal and enforceable but so as to most
nearly retain the intent of the parties, and if such modification is not
possible, such provision shall be severed from this Agreement, and in either
case the validity, legality and enforceability of the remaining provisions of
this Agreement shall not in any way be affected or impaired thereby.
16.11 Remedies Cumulative. No right, remedy or election given by any term
of this Agreement shall be deemed exclusive but each shall be cumulative with
all other rights, remedies an elections available at law or in equity.
16.12 Captions. The headings of this Agreement are inserted for convenience
only, shall not constitute a part of this Agreement or be used to construe or
interpret any provision hereof.
16.13 Amendments and Waivers. Any term of this Agreement may be amended and
the observance of any term of this Agreement may be waived only by mutual
consent of Healthworld and the U.K. Stockholder.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the day and year first above written.
-52-
Healthworld Agreement and Plan of Organization/Bourne
--------------------------------------------------------------------------------
HEALTHWORLD CORPORATION
By:__________________________________
▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, Chairman and CEO
And By:_______________________________________
▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, President
----------------------------------
▇▇▇▇▇▇▇ ▇▇▇▇▇▇
-53-
